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Abstract 
 
The principle calcium regulator in the muscle cell is the calcium ion release 
channel (RyR). Improper calcium homeostasis in the muscle cell is the 
foundation of many pathological states and has been targeted as a contributing 
factor to ventricular tachycardia, which is known to precede sudden cardiac 
arrest.  
Numerous endogenous and exogenous compounds can affect the way RyR 
regulates calcium. In this study the anthocyanidin Pelargonidin (Pg), an important 
natural colorant and dietary antioxidant, is evaluated for its effect on regulating 
the transport of calcium through the RyR1 of skeletal muscle sarcoplasmic 
reticulum. Pelargonidin undergoes time dependent structural changes in aqueous 
solutions at physiological pH and a mixture of up to seven forms of Pelargonidin 
are present in solution simultaneously. Pelargonidin is a unique RyR1 modulator. 
It can both stimulate and inhibit the RyR1 depending on the experimental 
conditions. In addition, when Pelargonidin is irradiated with white light, its 
inhibition properties on the RyR1 are essentially nullified. Proposed mechanisms 
include excited state charge shift within RyR1-Pg complexes. 
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1 Introduction 
 
 
Cardio vascular disease (CVD) causes more deaths than any other disease on 
the globe (World Health Organization). Although CVD encompasses numerous 
distinct pathological mechanisms, sudden cardiac death (SCD), the abrupt loss 
of heart function, is estimated to account for approximately 50% of CVD related 
deaths. A majority of the SCD fatalities is attributed to ventricular tachyarrythmias 
(VT) (Huikuri, Castellanos, and Myerburg 2001). In an effort to improve the 
quality of life for non-fatal CVD victims, reduce CVD deaths, and minimize the 
enormous economic costs associated with CVD, extensive epidemiological 
studies and laboratory research continue to be funded and performed in hopes to 
better explain the pathological molecular mechanisms of CVD.  
Non-behavioral risk factors of CVD include increasing age, male gender, and 
heredity related factors (children of people with heart disease and race related 
Figure 1.1 The Calcium Homeostasis Connection 
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increased risks). Behavioral risk factors (ones that we can change) account for 
over 90% of the risk of heart failures (HF). These factors include cigarette 
smoking, abnormal blood lipid levels (high cholesterol), hypertension (high blood 
pressure related), diabetes, abdominal obesity, a lack of physical activity, low 
daily fruit and vegetable consumption, alcohol over consumption, and 
psychosocial factors. (AHA-Heart and Stroke Update 4/2009 referenced Lancet. 
2004;364:937–952). 
Interestingly, a subsequent epidemiological study found an exception to that rule, 
the people of southern France consume more fat and smoke more cigarettes 
than other countries with a similar incidence of CVD deaths. Additional studies 
revealed that the same population also had a slightly different diet which included 
higher intakes of vegetables, fruits, and wine. The lower incidence of CVD was 
quickly attributed to the constituents of those foods which were abundant in 
flavonoid antioxidant compounds. Since then, research has been conducted on 
almost every conceivable natural antioxidant to be found in those foods. 
Extensive quantitative-structure activity relationship (QSAR) studies have 
characterized those compounds for their antioxidant properties. Naturally, those 
compounds that exhibited the highest level of antioxidant activity in vitro were 
perceived as the ‘best of the best’. These compounds have been studied 
extensively in the literature. If antioxidants are the ‘cure’, then it follows that 
oxidants may be the cause. Researchers targeted native reactive oxidant species 
(ROS) and studied their effects on the proliferation of CVD biomarkers in vitro. 
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The results all seem to imply that ROS cause severe damage to biological 
processes and can be attributed to increased incidence of several CVD 
pathologies. In addition to the ROS connection, recent studies (Lehnart et al. 
2004; A. Belevych et al. 2007; A. E. Belevych et al. 2008; A. E. Belevych et al. 
2009; A. Belevych and Terentyev 2010) related to ventricular tachyarrythmias, a 
significant contributor to sudden heart failure, have shown a connection between 
VT and increased levels (overload) of calcium (Ca2+) in the heart muscle cell via 
‘leaky’ calcium release ion channels (ryanodine receptor). The ryanodine 
receptor (RyR) is known to have reactive thiol residues that are extremely 
sensitive to the oxidation by ROS and numerous other compounds. Oxidation of 
these thiols can causes increased channel activity and Ca2+ conductance (J.J. 
Abramson and Salama 1988; Jonathan J. Abramson and Salama 1989; J. J. 
Abramson et al. 1988; J. J Abramson, Cronin, and Salama 1988). 
There may indeed be a connection between increased oxidative stress in the cell 
(oxidative stress) and abnormal calcium handling by the RyR (calcium overload) 
in cardiac myocytes, and deaths by ventricular tachyarrythmias. Dietary 
antioxidants that play a part in reducing ROS in the cell may also have a part to 
play in the decreased incidence of CVD deaths of those populations engaged in 
higher risk behaviors (disease related). However, numerous studies have shown 
that antioxidant compounds, especially the good ones, can also act as 
prooxidants. These antioxidant compounds have also been shown to bind to 
proteins and protective enzymes impacting their function (Graziani et al. 1982; 
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Kaldas et al. 2005). The intention of the investigation of various dietary 
antioxidants is to characterize that compound for its potential beneficial 
properties and its potential damaging properties so that fully informed and 
educated decisions can be made as to whether or not their benefits outweigh 
their risks. Due to the possible prooxidant activity of flavonoid antioxidants, it is 
clear that before recommendations can be made regarding their dietary inclusion, 
any impact that they may have on other biological systems must be understood. 
Given the importance of Ca2+ homeostasis in both skeletal and cardiac muscle, 
the interaction of these compounds need to be evaluated with regards to their 
possible modulation effects on the RyR. 
1.1 Oxidative Stress and Disease 
It is now well accepted that elevated ROS levels are associated with numerous 
bodily disease states including cardio vascular diseases, including but not limited 
to, atherosclerosis pathology (Khatri et al. 2004), cardiac hypertrophy (Higuchi et 
al. 2002), and myocardial lipotoxicity (Sharma et al. 2004). Abnormal ROS levels 
are also connected with a variety of cancers, Alzheimer’s Disease, inflammatory 
diseases (Hidalgo and Donoso 2008; Zima and Blatter 2006; A. E. Belevych et al. 
2009) as well as skeletal muscle fatigue and failure (Moopanar and Allen 2005). 
Lipid peroxidation and sulfhydryl group oxidation during ischemia-reperfusion can 
lead to abnormally high cell Ca2+ levels and contractile dysfunction (Dhalla et al. 
1999). Improper Ca2+ handling in the heart muscle has been connected to atrial 
arrhythmogenesis and contractile dysfunction in dogs with congestive heart 
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failure (CHF) (Yeh et al. 2008). Evidence has shown that reactive oxygen 
species (ROS) alter calcium pump function (Kourie 1998; Kaplan et al. 2003), 
alter calcium current reduction in L-type calcium channels (Guerra et al. 1996), 
and decrease contractility via altered calcium handling (He et al. 2003) in cardiac 
myocytes. Recently, there have been numerous studies pointing to Ca2+ overload 
via improper Ca2+ handling by the RyR as an underling cause of arrhythmias and 
sudden cardiac death (A. Belevych et al. 2007; A. E. Belevych et al. 2009).  
 
1.2 Oxidative Stress and Calcium Homeostasis in Muscle 
Calcium can signal and activate biological processes via dynamic variations in its 
concentration within cells. The concentration of free Ca2+ is generally controlled 
by its transport in and out of the cytoplasm of cells by ion channel proteins 
located in the membrane of the endoplasmic/sarcoplasmic reticulum organelles 
within the cell. This Ca2+ movement alters the cytoplasmic (intra-cellular) Ca2+ 
concentration which in turn impacts Ca2+ binding to various biological substrates. 
An important example of Ca2+ signaling is the binding of Ca2+ to specific muscle 
cell proteins. This interaction is mandatory for our muscles to contract and it also 
controls how much force is generated during the contraction. Indeed, without 
Ca2+ signaling, our muscles would cease to function and we would die. Improper 
functioning of the Ca2+ regulatory proteins can lead to pathological Ca2+ 
homeostasis conditions that can severely decrease the quality of human life and 
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also lead to eventual death. The importance of knowing how the Ca2+ level in 
muscle cells is regulated and knowing what causes changes in that regulation 
cannot be overstated. Studies to determine why muscles malfunction, fatigue, 
and fail have consumed researchers for many decades. Although the normal 
functioning of the muscle is the result of synergistic cooperation from numerous 
proteins that reside in the muscle cell, the main regulatory protein, the one that 
controls the fast Ca2+ transient signals within the cell, is called the ryanodine 
receptor (RyR). The RyR is, simply put, the valve that opens and closes 
controlling the concentration of Ca2+ within the cell. Increased Ca2+ levels allow 
for Ca2+-protein interactions that allow the contractile process of the muscle to 
occur. The RyR is very sensitive to the environment within the cell. It is sensitive 
to Ca2+ concentrations, the redox environment, binding of other closely 
associated proteins, and numerous other endogenous and exogenous 
compounds. All of these can have an effect on the way the RyR manages the 
Ca2+ level in the cell. This is of utmost importance because too much, or too little, 
Ca2+ can cause the concert of cooperation between the cellular proteins to 
breakdown which may lead to various pathological conditions and even death. It 
has been shown that one of the most important cellular conditions, with regards 
to proper Ca2+ homeostasis regulation by the RyR, is the redox environment 
within the cell (Jonathan J. Abramson and Salama 1989; Jonathan J. Abramson 
and Salama 1988; Trimm, Salama, and Abramson 1986). The redox potential in 
the cell is related to the relative ease by which the constituents in the cell 
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environment can reduce (donate electrons to) the RyR or oxidize (accept 
electrons from) the RyR. The RyR is a large homotetrameric membrane protein 
containing four subunits of ~5000 amino acids and ~565 kDa each totaling an 
approximate total molecular mass of 2.3 megadaltons (Du et al. 2002). The 
protein contains approximately 320-400 cytoplasmic, oxidation sensitive, cysteine 
residues (Xu et al. 1998). Many of these cysteines have thiol side chains that are 
very sensitive to oxidization. When the thiols are oxidized, intra-molecular 
cystines or cysteine-oxidizer adducts can be formed. It has been shown that 
some of the thiols on the RyR activate the channel when they are exposed to 
oxidizing conditions and that some of the thiols inhibit the channel when oxidized. 
(Jonathan J. Abramson and Salama 1988; Jonathan J. Abramson and Salama 
1989; Dulhunty et al. 2000). To maintain proper cell function, the redox potential 
of the muscle cell environment is kept in a tightly controlled and reduced state by 
the relative ratios (redox couple) of a few important endogenous compounds 
capable of cyclic redox states. The redox state of the cellular environment can be 
impacted by all of the cellular redox couples present with each couple 
contributing via an additive effect. However, due to its high concentration and 
respective reducing capacity, the glutathione disulfide/glutathione (GSSG/2GSH) 
couple is considered to be the main redox buffer of the cell and the state (value) 
of this couple alone is typically used as an indication of the state of the redox 
environment of the cell (Schafer and Buettner 2001). The relative concentration 
of GSH present in the cell, and consequently, the redox environment is impacted 
 7 
by the invasion of oxidative species. The main endogenous oxidative species are 
derivatives of either oxygen or nitrogen. In particular, oxidative free radical 
compounds, hydrogen peroxide, and derivatives of nitric oxide. These are 
commonly referred to as reactive oxygen species (ROS) or reactive nitrogen 
species (RNS). ROS are natively generated and released from the oxidative 
phosphorylation processes of the mitochondria in the cell and by other 
mechanisms such as xanthine oxidase (XO) and NAD(P)H oxidases. ROS can 
impart their damage by further increasing ROS levels via autoxidation reactions 
that further increase the levels of oxidants by directly attacking and altering 
(taking or donating electrons) cellular membranes and proteins causing altered 
function (Sen and Packer 2000). Increased levels of ROS can be generated 
during increased levels of exercise, exposure to environmental pollutants, and 
consumption of pro-oxidant compounds in food and beverages. In order to keep 
the redox environment tightly controlled (and in a reduced state), the body has a 
host of endogenous antioxidant defenses against these oxidants. Antioxidants 
are tasked with neutralizing the ROS by donating or accepting electrons or 
hydrogens to or from the ROS minimizing or nullifying its reactivity before the 
ROS reaches critical cellular substrates. In doing so, the antioxidant generally 
becomes a radical species itself but one that is more stable and relatively 
unreactive as compared to the original ROS. The main endogenous antioxidant 
compounds of the cell are glutathione (GSH), the glutathione peroxidase system, 
CoEnzyme Q, superoxide dismustase (SOD), and catalase. This defense 
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network is effective at protecting against various ROS under normal cell 
conditions but high levels of oxidants, generated during times of high oxygen 
consumption (strenuous exercise) or as a result of prooxidant intake (air 
pollutants or high fat diets), can overwhelm the endogenous defenses. These 
increased levels of oxidant compounds can easily overwhelm the endogenous 
antioxidants inducing a state of oxidative stress in the cell (M. J. Davies and 
Dean 1997; Fridovich 1978; K. J. Davies et al. 1982).  
 
1.3 CRC Modulation by Electron Donors and Acceptors 
Although redox control of the thiol-disulfide balance of the calcium release 
channel (CRC) is a well-established and accepted modulating mechanism of the 
CRC, the modulation by non-thiol compounds is less understood. The Abramson 
group has been accumulating evidence that non-thiol CRC modulators may work 
on the CRC via an electron donation or withdrawing mechanism (Marinov et al. 
2007; Ye et al. 2012). Through a patented free radical scavenging assay 
(Jonathan J. Abramson and Marinov 2012) involving the manipulation of dye 
radical (Methylene Blue) life-times and the resulting formation and measurement 
of superoxide reactive compounds (XTT), the relative electron donor and 
acceptor characteristics can be indirectly compared. They observed that well 
known CRC stimulators such as caffeine, doxorubicin, and mitoanthrone all 
exhibit electron accepting characteristics and that known CRC inhibitors, 
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tetracaine and procaine, exhibit electron donor characteristics. The modulation 
by caffeine and tetracaine, on ryanodine binding on the CRC indicated a 
competitive interaction. If the method of modulation of the CRC is indeed by an 
electron donation and accepting mechanism, the results imply that there is a 
common mutual site involved. Additionally, they looked at the affect that caffeine 
and tetracaine have on the redox potential of the skeletal muscle RyR (RyR1) 
and found that addition of caffeine, an electron acceptor, shifted the redox 
potential of the reactive thiols on RyR1 to more negative values, favoring thiol 
oxidation and a resulting channel open state. In contrast, tetracaine (an electron 
donor), shifted the redox potential to more positive values, favoring the thiol’s 
reduced state and a resulting shift to a more closed state of the channel. An 
additional assay performed utilizing the thiol labeling, florescent indicator CPM 
(7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin), showed that the 
number RyR1 thiols increased when in presence of the electron donor tetracaine 
(5μM) and decreased when in the presence of the electron acceptor caffeine 
(2mM). In all, the results established a correlation between non-thiol RyR1 
modulating compounds and their electron accepting and donating characteristics. 
RyR1 activators that shifted the redox potential to more negative values were 
also electron acceptors and RyR1 inhibitors that shifted the redox potential to 
more positive values are electron donors. The implications proposed are that 
these compounds act via a weak redox mechanism where the binding of these 
compounds results in a charge transfer complex that shifts electron density to or 
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away from the RyR1 which then allosterically influences the thiol-disulfide 
balance (Marinov et al. 2007). 
Also supporting this redox theory as a mechanism of RyR1 modulation, the 
Abramson group and Strongin groups chemically modified known RyR1 
modulating compounds by replacement or alteration of the compound’s 
functional groups. They modified the known RyR1 activator 4-CmC (an electron 
acceptor as measured by the dye scavenging radical assay previously mentioned) 
by replacing the chlorine group with a methoxy group they transformed 4-CmC 
from an electron acceptor to 4-MmC, an electron donor. At the same time, the 
known stimulating effects of 4-CmC on the RyR1 were transformed into inhibitory 
effects (lowering of single channel open probability) by 4-MmC. They also 
enhanced the electron donating properties of the antiarrhythmic drug K201 by 
substitution of a carboxy group for a methoxy group and the addition of dioxyl 
moiety to the compound. Again, the increased electron donating properties of the 
compound coincided with increased single channel inhibition effects (Ye et al. 
2012). 
The results thus far for the theory of charge transfer as an underlying mechanism 
for weak redox control of the CRC is promising and is applicable to the 
modulating mechanisms proposed for the effects that anthocyanidins have on the 
CRC as discussed in the following sections.   
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1.4 The Flavonoid Antioxidant – Calcium Homeostasis Connection 
1.4.1 Quercetin 
 
Figure 1.2 Structure of Quercetin 
Studies on the interaction of flavonoids with SR or the RyR are sparse. However, 
one popular flavonoid antioxidant, quercetin, has been shown to activate Ca2+ 
release from the SR skeletal muscle (Kim, Ohnishi, and Ikemoto 1983). 
Quercetin is a popular dietary antioxidant found in numerous vegetables, fruits, 
nuts, and teas. It has been extensively studied due to its excellent antioxidant 
properties and inclusion in numerous foods. Lee et. al. (Lee, Meissner, and Kim 
2002) showed that quercetin activates single RyR channel open probability (EC50 
of 91.0 +/- 15 µM at 10 µM Ca2+) more effectively than the well-known RyR 
activator caffeine (EC50 of ~2.93 mM at 10 µM Ca2+). Quercetin also exhibited a 
higher maximal open probability (Po=0.89 at 250 µM) as compared to caffeine 
(Po=0.66 at 9 mM). With regards to the redox sensitivity of the RyR, further tests 
were conducted to assay the effects of quercetin in the presence of the reduced 
and oxidized forms of glutathione (a cellular redox couple and as well as an 
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endogenous antioxidant). The results showed that the effects of 5mM GSSG (a 
RyR1 stimulant) plus 0.3mM quercetin on the RyR1 were not reversed by 5mM 
GSH (a RyR1 inhibitor). This may indicate that quercetin does not work via a 
redox dependent pathway. However, GSSG (EC50~0.09mM) has been shown to 
be a much more potent stimulator in single channel experiments than GSH is an 
inhibitor (IC50~2.4mM) (Zable, Favero, and Abramson 1997) and therefore the 
amounts of GSH and GSSG used by Lee et. al. may have played a part in the 
lack of inhibitory response by GSH. Lee et. al. also showed that the known 
stimulatory effects of K+-ATP on the RyR partially inhibited the stimulation by 
quercetin indicating that they may share the same binding site or that the effects 
of ATP on the channel may allosterically affect quercetin binding. These results 
are interesting from the stand point that quercetin appears to have a direct effect 
on the RyR yet not via a redox pathway.  This is surprising since quercetin has a 
catechol group (ortho hydroxyls) on its B-ring which is notorious for being 
oxidized to semiquinone radicals and quinones which have prooxidant properties 
and directly react with protein thiols (Metodiewa et al. 1999; Boots et al. 2003). 
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2 The Anthocyanidins 
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Figure 2.1 Anthocyanidin Structure 
Anthocyanidins are a subclass of flavonoids and are best known for the beautiful 
colors they impart to nature. They are responsible for most of the intense orange, 
red, blue, and purple colors exhibited in leaves, flowers, and fruits (Harborne, 
Mabry, and Mabry 1975). The chemical and biological properties of these 
compounds are very complex. Unlike other flavonoids, anthocyanidins are 
structurally unstable in weakly acidic to alkaline solutions. Upon exposure to 
these conditions, they will immediately start to transform into several different 
structural forms each with distinct chemical properties. The relative proportions of 
these forms is dependent on the pH of the solution and the  
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Figure 2.2 Pelargonidin (top), Cyanidin (middle), Delphinidin (bottom) 
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specific functionalization of the compound (Brouillard and Delaporte 1977; 
Brouillard and Dubois 1977; Brouillard, Iacobucci, and Sweeny 1982; Jurd 1963; 
Jurd and Geissman 1963; Jurd 1964; Jurd and Waiss 1965). Anthocyanidins are 
compounds of broad and intense interest due to their commercial value as 
potential food colorants, food preservatives (antioxidants), and, as of more 
recently, their potential health benefits.   
2.1 Anthocyanidin Structure 
Anthocyanidins are one of the six sub-classes of Flavonoids (itself being a sub-
class of polyphenols). They are compounds of the plant kingdom that have the 
general structure of a flavylium cation (2-phenylchromenylium) with a C6C3C6 
skeleton and with functionalization occurring at specific locations on the structure 
(see Figure 2.1). Functional groups are typically referred to by the number of the 
carbon to which it is attached (e.g. The C4’ hydroxyl or the 4’-OH). Additionally, 
the compound is also characterized by its rings A, B, and C. Anthocyanidins are 
salts and usually are identified along with a chloride counter ion. The counter ion 
dissociates with the main molecule in solution which leave a positive charge on 
the compound. Anthocyanidins provide most of the red to purple colors observed 
in flowers, leaves, fruits, and vegetables. They share a common function in the 
phyto-kingdom as pigments used to attract insects for pollination, cellular 
signaling molecules, anti-fungal protection, and UV light protection. Specific 
anthocyanidins are identified by how the base structure is functionalized with 
hydrogens, hydroxyl, methoxy, and sugar groups and the amount and type of 
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substitution contributes greatly to the color properties of the molecule. There are 
23 known anthocyanidins (Andersen and Markham 2006). Anthocyanidins have 
poor solubility in aqueous solutions but when sugar groups are attached 
(anthocyanins), they become more soluble and as such, that is the form that is 
found most in nature with more than 500 known anthocyanins documented. 
Although anthocyanins are the more prevalent, the functional properties of those 
compounds are typically attributed to the aglycon form (anthocyanidin) (Estevez 
and Mosquera 2008; Harborne, Mabry, and Mabry 1975).  
Six anthocyanidins that are considered to be the most important mainly due to 
their widespread distribution in nature are pelargonidin, cyanidin, delphinidin, 
petunidin, peonidin, and malvidin. Three of these six are considered to be the 
principle anthocyanidins due to their minimal substituent groups: delphinidin (Dp), 
cyanidin (Cy), and pelargonidin (Pg) (Figure 2.2). These three all have the same 
hydroxyl functionality on the 3, 5, and 7 carbons of the A and C rings. They differ 
in the amount of hydroxyl groups on the B-ring. The addition of hydroxyl groups 
to the B-ring (1 for pelargonidin, 2 for cyanidin, and 3 for delphinidin) causes a 
bathochromic (red) shift in their absorption spectrum. They have absorbance 
maxima at 530nm, 545nm, and 556nm (respectively) when prepared in acidified 
ethanol (Cabrita, Fossen, and Andersen 2000b).  
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2.2 Anthocyanidin Structural Equilibrium 
Anthocyanidins are native to the acidic conditions of the plant cell. Under these 
conditions, the anthocyanidins predominately exist in the ‘flavylium cation’ form 
as shown in Figure 2.2. Upon placing them in a more alkaline aqueous 
environment, they become unstable and their structure is altered in various ways 
depending mainly on the pH but temperature and light can also play a role. At 
very acidic pH, anthocyanidins exist almost exclusively in the flavylium cationic 
form (AH+) (see Figure 2.3).  When subjected to higher pH (~5), anthocyanidins 
exhibit three distinct chemical reactions involving proton transfers, hydration, and 
tautormerization. Upon a pH jump to ~5, deprotonation immediately occurs on 
the hydrogen (or hydrogens) of the flavylium cation with the lowest bond 
disassociation enthalpy (BDE) resulting in the quinoidal base form (A) or the 
quinoidal base anion form (A-). The flavylium cation (AH+) and the quinoidal base 
(A) quickly (<1 sec) come to an equilibrium. On a slower time scale (minutes to 
hours), AH+ undergoes hydration to obtain a mixture of the hemiketal (B/B-) and 
the cis and trans-chalcone isomers with mole fractions dependent on the specific 
anthocyanidin as well as the pH, temperature, and irradiation conditions. 
(Brouillard and Delaporte 1977; Brouillard and Dubois 1977).  
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Figure 2.3 Pelargonidin: Mixture of Forms  
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2.3 Anthocyanidin Chemical and Physical Properties 
2.3.1 Antioxidant Properties 
Antioxidants are compounds that inhibit or delay oxidative processes. They are 
available in the body as enzymes (SOD, catalase, glutathione peroxidase), 
various proteins (albumin, transferrin, haptoglobin), and low molecular weight 
antioxidants (tocopherol, carotenoids, glutathione, ascorbic acid, and 
polyphenolics). The generally accepted mechanism of action is either electron 
donation (or hydrogen) to a free radical or quenching of reactive oxygen or 
nitrogen species initiators (Vaya and Aviram 2001). For anthocyanidins, the key 
structural substituent(s) contributing to their antioxidant ability is the number of 
hydroxyl groups in the B ring. One hydroxyl, as in Pelargonidin, does not seem to 
contribute greatly to antioxidant properties. Addition of a second hydroxyl in an 
catechol like structure (cyanidin) greatly enhances antioxidant activity. The 
addition of a third hydroxyl in a pyrogallo like structure (delphinidin) continues to 
increase antioxidant activity but only slightly over that of cyanidin (Rice-Evans, 
Miller, and Paganga 1996). The catechol groups are very easily oxidized and its 
mechanism of antioxidant action is probably by electron donation and formation 
of a semiquinone moiety. The donation of a second electron then will form a 
quinone. (Van Acker et al. 1996; A. Sekher Pannala et al. 2001). Pelargonidin 
only has a mono-hydroxyl B-ring and is a less effective antioxidant. Its 
mechanism of action is probably by donation of an electron and subsequent 
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formation of a phenoxyl radical (Galati et al. 1999; Ananth Sekher Pannala et al. 
2001).  
Pelargonidin, cyanidin, and delphinidin all exhibit superoxide and hydroxyl 
scavenging activity and can inhibit hydrogen peroxide induced lipid peroxidation. 
In a study of pomegranate extract, a hypoxanthine-xanthine oxidase superoxide 
generating system where DMPO-OOH spin adducts (indicator of superoxide 
concentration) were measured by ESR, Pg, Cy, and Dp scavenged super oxide 
with IC50 values of 456µM, 22µM, and 2.4µM respectively. It was noted that due 
to the mono-hydroxyl in Pg, its mechanism of action may involve indirect rather 
than direct scavenging and possibly by more than one scavenging mechanism 
(Noda et al. 2002)  
Dp and Pg also were shown to inhibit H2O2 induced lipid peroxidation in rat brain 
homogenate when H2O2 and Pg, Cy, and Dp were incubated together with the 
brain substrate for 60 minutes (IC50=85µM, 3.5 and 0.7µM respectively) (Noda et 
al. 2002).  
In a similar study (grape seed, etc), Pg, Cy and Dp also exhibited excellent 
scavenging properties for superoxide, hypochlorite ion, hydroxyl radical, and 
linolenic acid with the only exception being that Pg did not exhibit superoxide 
scavenging properties in this study (Wada et al. 2007). 
The radical scavenging ability of anthocyanidins is strongly pH dependent. In a 
study by Borkowski et al., the Trolox Equivalent Antioxidant Capacity (TEAC) 
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antioxidant assay was utilized to compare the antioxidant actions of different 
anthocyanins relative to a water soluble vitamin E analog (Trolox). The TEAC 
assay is based on the ABTS•+ (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic 
acid) radical and the ability of the antioxidant to scavenge it and thus reduce its 
characteristic absorption spectrum. The results indicated that for these 
anthocyanidins,  ABTS•+ scavenging activity increases with both the number of 
hydroxyl groups on the B ring (i.e. – Dp>Cy>Pg) and with increasing pH (except 
not for Pg). The pH dependent enhancement corresponded to the deprotonations 
of the C4’ hydroxyl (pKa1~5.3 experimentally determined) and its C5 hydroxyl 
(pKa2~6.3 computationally predicted) of Dp. The deprotonations of the C4’ 
hydroxyl (pKa1~5.48 experimental) and its C5 hydroxyl (pKa2~6.39 computational) 
of Cy. Pg on the other hand had an activity similar to Trolox but did not show a 
significant increase in activity with the deprotonation of C5 (pKa1~5.79 
(experimental)) and the deprotonation at C4’ (pKa2~7.05  (computational)) 
(Borkowski et al. 2005). Addition of a sugar group at position C3 to Cy and Dp 
decreased the scavenging abilities by up to 50% at pH > ~6.  
2.3.2 Prooxidant Activity 
To add to the complexity, under certain conditions, Pg, Cy, and Dp can exhibit 
prooxidant properties. Delphinidin’s and Cyanidin’s tri-hydroxy and di-hydroxy 
groups in the B-ring are highly oxidizable and autoxidation of these groups is 
possible at physiological pH. Autoxidation is accompanied by generation of 
superoxide and hydrogen peroxide (Hodnick et al. 1986; Hodnick et al. 1988). 
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This property may also be enhanced by their metal chelating ability which is also 
known to catalyze the autoxidation of (similarly oxidizable) catechol groups 
(dihydroxy group) (Vanacker et al. 1995; Canada et al. 1990; O. Dangles, 
Fargeix, and Dufour 2000).  
Pelargonidin, with only a monohydroxyl group in the B-ring, does not exhibit 
autoxidation and doesn’t chelate metals. Its reduction in hydrogen peroxide 
induced lipid peroxidation activity may be due to a different oxidation mechanism 
(Van Acker 1996). In one study, it was found that the phenoxyl radicals of 
similarly structured compounds with a mono-hydroxyl substituted B ring redox 
cycled and caused extensive GSH oxidation at pH~7 to form thiyl- radicals which 
reduced oxygen. Surprisingly, flavonoids containing a catechol B-ring did not 
show the same oxidative properties (Galati et al. 1999). 
In a LDL (low-density lipoprotein) oxidation assay (Satue-Gracia, Heinonen, and 
Frankel 1997), both Dp and Pg act as prooxidants when 3μM copper is used as 
an oxidation initiator. Interestingly, when 10µM copper is used, Pg acts as an 
antioxidant and Dp continues to be prooxidant. It was noted that more work was 
needed to be able to propose a mechanism for why Pg changes its 
antioxidant/prooxidant activity with various copper concentrations. 
2.3.3 Anthocyanins as Superphotoacids 
Anthocyanins provide protection to plant tissues via an energy wasting 
mechanism that involves fast adiabatic proton transfer to water. This mechanism 
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is also responsible for the typically weak fluorescence of the anthocyanin cation 
form. Laser pulse photolysis experiments have shown that when anthocyanin 
cations (low pH) of Pelargonin, Cyanin, Malvin, and Oenin are excited to their 
first excited single state, emission from both the excited cation and the excited 
quinoidal base is observed indicating ultra-fast excited state proton transfer (from 
the cation) to water. Proton transfer rate constants obtained were utilized to 
roughly calculate the pKa’s which, upon excitation, decrease by approximately 4 
pK units (4.44 to 0.14 for pelargonin) (Moreira et al. 2003). Hence, the 
anthocyanin cation form is a weak acid in the ground state but is a very strong 
acid in the excited state. The same trend may occur for the excited states of the 
quinoidal base and the ionized quinoidal base however the amount of pK shift 
has not been published to the best of my knowledge.    
 
2.3.4 Anthcyanin Copigmentation and Self-Association 
Anthocaynins can form complexes with colorless flavonoids copigments 
(polyphenols, flavonoids, alkaloids, and amino acids) which results in color 
enhancement and increased stability of the colored forms of the anthocyanidin 
(Brouillard et al. 1989; Asen, Stewart, and Norris 1972). Anthocyanidins can also 
self-associate as a mechanism to stabilize their color (Olivier Dangles, Saito, and 
Brouillard 1993) and self-associations between the cations, quinoidal base, and 
ionized quinoidal base forms as well as mixtures of these forms have been 
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observed (Hoshino, Matsumoto, and Goto 1980; Hoshino, Matsumoto, and Goto 
1981). The main driving force for complexation is proposed to be either 
hydrophobic solvent interactions (Robinson and Robinson 1931) (historical) or 
more recently proposed, a charge transfer complex (Ferreira da Silva et al. 2005). 
The (electron density) charge-transfer from the copigment (the electron donor) to 
the anthocyanidin (the electron acceptor) theoretically should decrease the 
positive charge at carbon 2 resulting in a reduction in the equilibrium constant for 
hydration. Additionally, charge density on the hydroxyl oxygens should increase 
decreasing the ease of deprotonation. This is consistent with the observed color 
enhancement and stability of these complexes (Ferreira da Silva et al. 2005; 
Quina et al. 2006).  
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2.3.5 Anthocyanin Excited State Redox Activity 
It has been reported that photo excitation of charge transfer complexes results in 
fluorescent quenching due to fast electron transfer from the copigment to the 
flavylium cation (Ferreira da Silva et al. 2004). The high efficiency of electron 
transfer results from the high oxidizing power in the excited state of the cation 
form. The authors also stated that as a consequence of the cations high 
reduction potential, the excited singlet state of the flavylium cation form should be 
capable of oxidizing most polyphenols as well as biomolecules such as tyrosine  
and tryptophan. 
 
2.3.6 Photochromism 
Photochromism is the transformation from one chemical species to another 
species by absorption of radiation. Within the flavylium network (Figure 2.3), 
there are two processes that will cause the transformation of color. Light 
absorption by the trans-chalcone allows it to overcome the isomerization barrier 
and (back) transform to the cis-chalcone species. Additional absorption of light by 
the cis-chalcone allows catalyzed ring closure to the hemiketal. Once the 
hemiketal is formed, acid catalyzed loss of water gives the cation and then the 
quinoidal base and ionized quinoidal base depending on pH. When irradiation is 
removed, the system will revert back to the thermally favored forms (Pina et al. 
1998).  
 26 
2.4 Pelargonidin 
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Figure 2.4 Molecular Structure of Pelargonidin Cation 
 
Pelargonidin (Figure 3.4) was first obtained by Willstater and Bolton in 1914 by 
the hydrolysis of pelargonin of Pelargonium zonale. It has absorbance maxima in 
the 530nm (in EtOH-HCl). Pelargonidin is found in the skin of the red radish, 
strawberries, petals of geraniums, and the rose (among others). 22 glycosides of 
pelargonidin are known (Harborne 1967). Pelargonidin has hydroxyl (–OH) 
groups at the 3, 5, 7, and (para) 4’ positions. The structural configurations of 
pelargonidin are shown in Figure 3.3. When exposed to increasing pH conditions, 
compounds with a monohydroxylated B ring (pelargonidin) exhibit a gradual 
bathochromic (red) shift up to pH~6, an extensive red shift from pH~6 to pH~7.3, 
and a stable λmax  from pH7.3 to pH~10-11(Cabrita, Fossen, and Andersen 
2000a).  These color changes are caused by structural changes as mentioned in 
the previous sections. Although the first pKa (pKa1) can be determined 
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experimentally, subsequent deprotonation pKa’s (pKa2 etc.) are difficult to 
determine experimentally due to the simultaneous existence of multiple forms of 
the compound in solution. Thus, to predict the pKa of subsequent deprotonations 
of each structural form, quantum mechanical calculations determining the 
disassociation energies of each hydrogen must be performed. The lowest 
computed bond-dissociation energy (BDE) based on the lowest energy structures 
are considered the first to deprotonated. In reality, there may be several similarly 
valued low energy structures and several hydrogens with similarly valued BDE 
which implies a mixture of compounds in solution at all times. When subjected to 
a neutral pH environment, pelargonidin rapidly deprotonates and changes from 
the flavylium cation from to its quinoidal base form. The first deprotonation is 
experimentally been shown to be at pH 5.79. The favored deprotonation site as 
calculated numerically is the 5-OH group. The predicted pKa2 for the quinoidal 
base form is at pH 7.05 and located at the 4’-OH (Borkowski et al. 2005).  
3 Material, Methods, and Controls 
3.1 Materials 
3.1.1 Sarcoplasmic Reticulum 
Sarcoplasmic reticulum is isolated from fast twitch back and hind leg skeletal 
muscle extracted from 2-3 kg New Zealand white male rabbits according to 
protocols approved by Portland State University’s Institutional Animal Care and 
Use Committee (IACUC) (also reference (MacLennan et al. 1973)). Live rabbits 
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were euthanized and placed on ice. Removed muscle was also placed on ice. 
Fat and red muscle is trimmed from the fast twitch muscle and discarded. Fast 
twitch muscle is cut to approximately 1-2 cm3 peices and placed into a cold 
proteolysis inhibiting buffer of 120mM NaCl, 10mM imidazole, 100µM DTT, 
100µM EGTA, 0.2μg/ml leupeptin, and 0.1mM PMSF at pH 7.4. Muscle is then 
homogenized with a common household blender (Waring) by a 4X repeating 
cycle of 15 sec at low speed, 60 sec high speed, and 30 sec of no blending. 
Homogenate is then centrifuged at 1,600×g for 10 minutes. Supernate is then 
filtered through four layers of cheesecloth to remove excess debris and fat. 
Remaining homogenate is adjusted to pH 7.4 with imidazole and centrifuged at 
10,000×g for 15 minutes to remove mitochondria. Supernate is retained and 
centrifuged at 44,000×g for an additional 70 minutes to collect SR. Supernatant is 
discarded and the remaining pellet is homogenized to approximately 10mg/ml 
with a buffer of 120mM NaCl, 10mM imidazole, 100µM DTT, and 50µM EGTA at 
pH 7.4. The resulting homogenate is then centrifuged at 7,500×g for 10 min to 
remove remaining myosin. Supernatant is retained and centrifuged at 78,000×g 
to obtain the SR pellet. The pellet is then homogenized to approximately 
20mg/ml in a buffer of 100 mM KCl and 20 mM HEPES at pH 7.0. Aliquots of SR 
are put in cryo-storage tubes and stored in liquid N2 until needed. The protein 
concentration of the SR is then quantified by the method of Kalckar (Kalckar 
1947) where the 280nm absorbance of aromatic amino acids tyrosine and 
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tryptophan combined with the 230nm absorbance of the peptide backbone is 
utilized to determine the total protein concentration. 
3.1.2 Anthocyanin’s 
Pelargonidin chloride (CAS#134-04-3) and Cycnidn (CAS#528-58-5) are 
purchased from Sigma Aldrich. Delphinidin chloride (CAS#528-53-0) is 
purchased from Extrasynthese (France).Ca2+ Ion Selective Electrode (Ca2+-ISE) 
Materials 
Materials (and supplier) for the fabrication of the Ca2+-ISE are as follows. The 
POCO EDM3 Rod (Saturn Industries), stainless steel braid and abrasive paper 
were standard off the shelf,  conductive glue (Radio Shack #6400146), 
potassium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (CAS#105580-52-9) 
(SIGMA), Tetrahydrofuran (CAS#109-99-9) (freshly distilled) (PSU Chemistry 
Dept), Polyvinyl Chloride High Molecular Weight (CAS#9002-86-2) (SIGMA), 
Fluka 2-Nitrophenyl octyl ether - Selectophore (CAS#37682-29-4), Calcium 
Ionophore II –Selectophore (CAS#74267-27-9) (SIGMA). 
3.1.3 Miscellaneous Materials 
Calium ionophore A23187 (SIGMA), EtOH is 95% distilled by PSU Chemistry 
Department, MeOH is analytical grade anhydrous >99.5%, water is 18 Mohm 
from a Mili-Q System (Millipore Co), EGTA (SIGMA), Lactate Dehydrogenase 
(SIGMA), NADH (SIGMA), Pyruvate Kinase (SIGMA), Phosphoenol pyruvate 
(SIGMA), SOD (SIGMA). Catalase (SIGMA), and all other reagents (HEPES and 
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PIPES buffers, calcium, magnesium, salts, etc) were of typical laboratory grade 
unless noted.  
 
3.2 Methods 
3.2.1 Active Efflux Experiments 
SR vesicles are suspended at typically 0.1-0.2 mg/ml final concentration in an 
efflux buffer of 100mM KCl, 20mM HEPES or PIPES at the required pH. The 
Ca2+-ATPase of the SR is activated by the addition of 20-200μM of Mg2+-ATP. 
Ca2+ is loaded into the sSR and allowed to leave the sSR through the CRC. The 
Ca2+ release rate is then measured and the relative degree of CRC modulation 
can be compared (Martonosi and Feretos 1964a; Martonosi and Feretos 1964b; 
Ogawa et al. 1971).   
Figure 3.1-A shows a typical active efflux experimental trace of the Ca2+ 
electrode signal (mV) versus time for both a control (no modulator) and a trace 
with a 30μM Pg addition. First, SR and buffer (same buffer and pH as used in the 
experiment) are premixed (1:1) at approximately 10mg/ml to 15mg/ml [protein] 
depending on the stock SR concentration.  Then approximately 250 µM CaCl2 is 
added to the SR premix. The SR-buffer premix is made to make the SR less 
viscous and allow for more repeatable pipetting. The CaCl2 is added to eliminate 
a pipetting step and to minimize variability. MgCl2 and ATP are premixed at a 2:1  
MgCl2 : ATP ratio (again to minimize variability). However, it is common to add 
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some or all of these compounds separately (not premixed) as well. The start of 
the active efflux experiment is the addition of the SR/CaCl2 premix (~0.15mg/ml 
/~5µM final concentration) where the first large rise in the Ca2+-ISE signal is 
measured. To initiate the Uptake Phase, Mg2+-ATP (60µM MgCl2 : 30 µM ATP) is 
added to activate the Ca2+-ATPase which will then pump Ca2+ into the SR. This 
results in a decrease in extra-vesicular [Ca2+] and a corresponding decrease in 
the Ca2+-ISE signal. A pseudo steady state condition is achieved (Uptake 
Minimum) when the amount of Ca2+ being pumped into the lumen of the SR by 
the Ca2+-ATPase is equal to the amount of Ca2+ being released by the CRC. In 
the assay utilized for this work, the amount of Mg2+-ATP is optimized so that the 
steady state phase is short lived. As the extra-vesicular [Ca2+] increases, the 
CRC becomes more stimulated by the [Ca2+] which causes additional Ca2+ 
modulated stimulation. This process repeats itself in a positive feedback loop 
increasing the rate of Ca2+ efflux until the Ca2+ gradient across the SR is depleted 
and the efflux rate slows until equalized and net efflux is zero. This Ca2+ 
stimulated feedback loop is recognized as a sigmoid-like Ca2+ signal (Calcium 
Modulated Calcium Release –CMCR Phase). 
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 Figure 3.1 Phases and Analysis Points of a Typical Active Ca2+ Efflux  
Experiment. 
Control (light grey) and 30μM Pg (black) efflux experiments  
A. The seven main experimental phases: +SR/ Ca2+ (loading), +Mg2+-ATP 
(initiate uptake), Uptake Phase, Uptake Minimum (pseudo steady state), 
+Pg (modulator addition – none for control), Initial Rate of Ca2+ Release 
(IRCR), Ca2+ Modulated Ca2+ Release (CMCR) Phase. 
B. Efflux Analysis Points: IRCR maximum (IRCRmax) and CMCR rate 
maximum (CMCRmax).  
Experiments shown were performed in a 100mM KCl 20mM PIPES efflux buffer 
at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 + 30μM ATP 
(premixed). At uptake minimum [Ca2+]~1 μM  
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If a CRC stimulator like 30μM Pg is added at the Uptake Minimum (identified by 
an electrical spike artifact as a result of bringing the pipette close to the Ca2+ 
electrode), an increase in the extra-vesicular [Ca2+] is observed (signal increase) 
as a result of an increased efflux of stored Ca2+ from within the SR. In this work, 
the maximum rate of Ca2+ release observed during this phase is noted as Initial 
Rate of Calcium Release - IRCRmax (Figure 3.1-B). Similarly, the maximum rate 
during the CMCR phase will be denoted CMCRmax. The experimental 
instrumentation set-up consists of a grounded aluminum work enclosure 
(‘Faraday Cage’) approximately 0.3m x 0.3m x 0.3m in size with a hinged door 
and a removable top. Inside the enclosure is a vertical aluminum rod with an 
attached adjustable electrode holder that allows the Ca2+ electrode and reference 
electrode (World Precision Instruments DRIREF-2) to be raised, lowered, and 
adjusted to the sample cuvette. Also included is a machined acrylic block fixed to 
the bottom of the chamber to allow for repeatable and easy positioning of the 
sample cuvette. The block also allows for the positioning of the two fiber optic 
light pipes (Dolan Jenner Fiber-Lite 180 with IR cutoff filters) for use in irradiation 
experiments. A magnetic stirring plate is positioned under the aluminum 
enclosure and provides constant mixing capability in the sample cuvette The 
Ca2+-ISE and reference electrode are connected to a Chemtrix Type 60A pH/mV 
meter with mV analog outputs. The mV outputs are connected to an AXON 
Instruments Mini-Digi 1A analog to digital converter. A computer running AXON 
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Instruments AxoScope 9.0 is used to observe and record the signal. Data is 
analyzed in Excel 2010 or SigmaPlot 10. 
3.2.2 Calcium Ion Selective Electrodes (Ca2+-ISE) 
The Ca2+-ISE used in this work are custom fabricated in this lab. The basic 
structure of the probes are based in part by the early works of Moody (Moody, 
Oke, and Thomas 1970) presenting on Ca2+ sensitive electrodes based on a 
liquid ion exchanger embedded in a polyvinyl chloride (PVC) membrane and of 
Ansaldi and Epstein (Ansaldi and Epstein 1973) reporting on a Ca2+-ISE in which 
a PVC membrane directly contacts a graphite rod. Further improvements in 
membrane formula (+ETH129) with regards to ion species selectivity and the limit 
of detection (LOD) of the membrane were presented by Schefer et al. (Schefer et 
al. 1986) and is also utilized here. General mixing and formulation procedures 
published by Baudet, hove-Madsen, and Bers were also considered. (Baudet, 
Hove-Madsen, and Bers 1994)  
3.2.2.1 ISE Theory 
The Ca2+-ISE fabricated and utilized in this work incorporates a PVC membrane 
partition that is functionalized with a mixture of compounds that allow Ca2+ to 
selectivity be transported through the membrane. The Ca2+ selective membrane 
is formed on the end of a solid state graphite rod that has its other surfaces 
encapsulated and insulated by a non-functionalized and impervious PVC sheath. 
When the functionalized membrane end is immersed into a solution with free 
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Ca2+ions, the Ca2+ ions diffuse into the membrane causing an internal positive 
charge within the membrane. Simultaneously, a negative charge builds up on the 
solution side of the membrane (due to the loss of positive Ca2+ ions) until 
eventually, the diffusion pressure and the electrostatic forces are balanced and 
the diffusion stops. The resulting difference in charge across the membrane is 
the membrane potential and when compared to a reference electrode in the 
solution without the functionalized membrane, the membrane potential can be 
measured by a high impedance electrical meter with mV capability. There are 
other junction potentials within the ISE system but those are constant and are 
manifested as a constant offset voltage. 
3.2.2.2 Nernst Relationship 
The electrical potential that develops across the membrane due to an inequality 
of active redox species can be characterized by application of the Nernst 
equation. The Nernst equation is formally used for measuring redox reactions 
and allows the determination of the relative activities of the ion being measured.  
However, in the case of potentiomeric measurements with ion selective 
electrodes where there aren’t any redox reactions occurring, the modified Nernst 
equation (Equation 3.1) is also applicable.  
 36 
Equation 3.1   0 2( / ) log[ ]E E RT zF Ca += −     
  
Where E is the measured membrane potential, E0 is the sum of the potentials on 
the electrode side of the membrane and any other junction potentials in the 
system. The RT zF term includes; R the gas constant (8.31 J/mol*K), T the 
temperature (295K), z the species charge (2 for Ca2+), and F the Faraday 
constant (96,485 Coulomb/mol). The result of that term including a 2.3 factor for 
conversion to base log10, is 0.029 V. Substitution into Eq. 3.1 yields: 
Equation 3.2   0 21029*log [ ] ( )E E Ca mV
+= −  
 
Where E  is the measured potential in mV. This equation describes a line with a 
slope of 29 mV / decade change of [Ca2+].  
 
3.2.2.3 Probe Fabrication  
A ~10 cm length of 0.0625 in or 0.125 in diameter graphite rod (Saturn Industries 
POCO EDM3 Rod) is cut and wiped well with a Kimwipe wetted with 200 pf EtOH 
and then dried with nitrogen gas. A length of a small diameter (~0.125 ID) 
shielded coax cable is cut and striped at each end leaving approximately 2 cm of 
braid showing. The center conductor plus insulation is pulled out and discarded. 
One end of the exposed braided shielding is cleaned with 200 pf EtOH and blown 
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dry with nitrogen (repeated 3x). The cleaned end of the shielding is expanded 
with an awl as to allow insertion of the graphite rod. The expanded steel braid is 
then partially filled with a graphite based conductive glue (Radio Shack 
#6400146).  The electrode is then inserted into the braid and the braid is then 
pulled as to tighten it around the rod (like a Chinese finger trap). The exuding 
glue is spread evenly to coat the steel braid and carefully set aside and allowed 
to air dry overnight. The next day, a length of an appropriate diameter PVC heat 
shrinkable tubing (Insultab 30PVC) is cut to a length long enough to cover the 
graphite rod and the exposed coax shielding glued to the rod. The heat 
shrinkable tube is then applied by a hot air gun to securely fit the insulation to the 
electrode. To prepare the non-pigtailed end of the electrode for accepting the ion 
selective membrane, it must be sanded smooth and the PVC jacket must be level 
with the electrode rod. A majority of the (working) electrodes prepared for use in 
this work have been sanded to a visibly shiny surface in two dry steps with 600 
then 1500 grit waterproof sandpaper. Finally, the exposed electrode surface is 
gently rubbed in a circular motion on a Kimwipe to clean off loose particles and 
then it is blown clean with a strong stream of nitrogen gas.  
3.2.2.4 Ion Selective Membrane Preparation and Application 
Prepare in advance the PVC-ionophore solution as described by Baudet et al. 
(Baudet, Hove-Madsen, and Bers 1994). With a small volume pipette, dispense 
between 5 and 10 μl of the solution in the center of the watch glass and 
immediately discard the tip to minimize THF vapors from permeating the internals 
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of the pipette. Immediately dip and swirl the end of the electrode into the solution 
and then remove and invert the electrode (dipped end up). Place in a holder for 
solvent to evaporate. The remaining solution on the watch glass will begin to dry 
and should be wiped away with a clean Kimwipe. Several more electrodes can 
be dipped while the previously dipped ones are drying. Typical dry times for this 
first membrane solution application process is approximately 15 minutes (other 
times not evaluated). Once the set of electrodes has been dipped once. Repeat 
process. Two dip applications of the membrane solution seems to be adequate 
for achieving a sufficiently functional membrane. Electrodes should be allowed to 
dry overnight to allow complete removal of any residual THF. 
3.2.2.5 ISE Conditioning 
The ISE should now be conditioned in an unstirred aqueous CaCl2 solution (no 
buffer) for 1 to 3 days as needed. This is a qualitative process as the degree of 
required conditioning can vary (possibly dependent on the thickness of the 
membrane). I have found that conditioning in 1 mM CaCl2  for 2 days usually 
produces a working electrode. However, I have also seen electrodes that show 
slow response times even after 2 days and a 3rd day of conditioning improved its 
performance dramatically. 
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3.2.2.6 Ca2+-ISE Calibration – Standard Addition 
When a new probe is put into use for the first time after fabrication and 
conditioning, it should be checked for its functionality. Specifically, its limit of 
detection and response time should be characterized. 
The Ca2+-ISE mV response to p[Ca2+] relationship should be verified to be linear 
and with a near Nernstian slope. ISEs with slopes that are not Nernstian, that is, 
not near the theoretical value of 29 mV/p[Ca2+], could technically be used as long 
as the sensitivity is adequate and the response is linear over the desired 
measurement range. However, a deviation from Nernstian characteristics can be 
an indication of a defect in the Ca2+-ISE and therefore the user should proceed 
carefully. Approximately 1 in 5 probes fabricated were not functional probably 
due to membrane defects or leaks. Working electrodes had a typical response 
range of ~27 to ~30 mV/p[Ca2+].  
3.2.2.7 Ca2+-ISE Calibration 
To calibrate the response of a Ca2+-ISE and to determine the buffer Ca2+ 
concentration ([Ca2+]buf), the method of standard addition can be used. The Ca2+-
ISE response is linearly proportional to the p[Ca2+]. Once a Ca2+-ISE is placed in 
the assay buffer and its signal verified to be sufficiently stable, successive 
additions of known [Ca2+] additions are made and plotted. Preferably, the [Ca2+] 
used for calibration should be in the same range of the [Ca2+] present in a typical 
experiment.  
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The calibration of a Ca2+-ISE can be separated into two [Ca2+] ranges. A range 
higher than [Ca2+]buf and a range lower than [Ca2+]buf. To calibrate the Ca2+-ISE in 
the higher than buffer range, one just needs to use the typical standard addition 
method by adding a known amount of Ca2+ and correlating the response. This is 
also effective for determining the [Ca2+]buf  (assuming a linear response in that 
[Ca2+] range). To calibrate the Ca2+-ISE in the [Ca2+] range lower than [Ca2+]buf , a 
Ca2+ chelator system must be used. 
Once a linear (Nernstian) Ca2+-ISE response is confirmed, the mV signal from 
the ISE can easily be converted to [Ca2+] which is desired for reporting efflux 
activity of the sSR. 
3.2.2.8 Calibration in the [Ca2+]high range (higher than [Ca2+]buf) 
Once a Ca2+-ISE is placed in the assay buffer and its signal verified to be 
sufficiently stable, multiple additions of a known amount of Ca2+ are added. The 
signal of the Ca2+-ISE should be allowed to stabilize between successive 
additions. Once the desired number of data points are obtained, the mV signal vs 
the p[Ca2+] response should be plotted for analysis (Excel or other). Figure 3.2 
shows a simple worksheet used for calibration analysis. The black unfilled circles 
are the known additions and the black unfilled square data point is the [Ca2+]buf 
‘fitted’ value. The [Ca2+]buf value can be found by utilizing Excel’s Solver function 
and having it solve for the best fit (highest r2). To verify that the linearity of the 
probe response falls below the extrapolated value of the [Ca2+]buf, a calibration in 
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the [Ca2+] range that is lower than the buffer should be performed. For an 
acceptable Ca2+-ISE, the analysis should yield a slope in the range of 27 to 30 
mV/p[Ca2+]. 
3.2.2.9 Calibration in the [Ca2+]low range (lower than [Ca2+]buf) 
Working in a [Ca2+] range that is lower than the [Ca2+]buf  generally requires a 
Ca2+ chelator to be used. The first objective is to produce a [Ca2+] calibration 
curve in the [Ca2+]high range that can also be used to confirm the expected linear 
Ca2+-ISE response in the [Ca2+]low range. The main consideration is to obtain 
several chelating response steps in the same [Ca2+]high range and, in addition, 
obtain a sufficient amount of data in the [Ca2+]low range (Figure 3.2 data marked 
with ‘x’). Chelating steps should be performed as needed to chelate the [Ca2+] 
down well below the desired working [Ca2+] range of the assay. This may be 
lower than the Ca2+-ISE’s limit of detection (LOD) and out of the linear response 
range of the probe. Extreme diligence is then required to ensure accurate 
conversions from the mV signal of the probe to the desired calcium concentration. 
The range of calcium concentrations encountered in this work are relatively high 
(>2 orders of magnitude) as compared to the LOD of these probes and therefore 
the procedure for determining the LOD is not covered here. The typical LOD of 
the Ca2+-ISE fabricated for this work have LODs of less than 100nM.  
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 Figure 3.2 Excel Worksheet for the Determination of Ca2+-ISE Linearity, mV to 
[Ca2+] Transform Equation, and Predicted Buffer [Ca2+]  Excel Worksheet 
Chart at top shows the data points [Ca2+]high (○), [Ca2+]buf predicted (□), and [Ca2+]low 
(×).  
Results from below….
Results slope y-intercept r2
Calculated 
[Ca2+]buf
[Ca2+]high Linear Fit 30.0 421.2 0.999 1.4E-06
[Ca2+]low Linear Fit 30.6 423.6 0.997
Linear fit of all data 
[Ca2+]high and 
[Ca2+]low
30.6 423.7 0.998
Enter values into green cells Everything else is calculated
STEP 1 : [Ca2+]high Response
Total Sample 
Volume (L)
Stock Added 
Ca2+ (L)
Stock 
[Ca2+] (M)
Added 
moles of 
Ca2+
Cumulative 
moles of Ca2+
Sample 
[Ca2+] M
Adjust for 
best r2
p[Ca2+]
Electrode 
Response (mV)
Starting Volume 5.000E-03 6.86E-09 1.4E-06 -5.86 245.4
Addition #1 5.005E-03 5.00E-06 0.02 1.00E-07 1.07E-07 2.1E-05 -4.67 280.6
Addition #2 5.010E-03 5.00E-06 0.02 1.00E-07 2.07E-07 4.1E-05 -4.38 290.2
Addition #3 5.015E-03 5.00E-06 0.02 1.00E-07 3.07E-07 6.1E-05 -4.21 295.8
Addition #4 5.020E-03 5.00E-06 0.02 1.00E-07 4.07E-07 8.1E-05 -4.09 298.0
Addition #5 5.025E-03 5.00E-06 0.02 1.00E-07 5.07E-07 1.0E-04 -4.00 301.0
STEP 2 : [Ca2+]low Response
Total Sample 
Volume (L)
Stock Added 
EGTA (L)
Stock 
[EGTA] M
Added 
moles of 
EGTA
Cumulative 
moles of 
EGTA
Sample 
[EGTA] M
BAD 
Calculated 
[Ca2+] M
Calculated 
p[Ca2+]
Electrode 
Response (mV)
Starting Volume 5.025E-03
Addition #1 5.035E-03 1.00E-05 1.93E-02 1.93E-07 1.93E-07 3.84E-05 6.30E-05 -4.20 295.4
Addition #2 5.040E-03 5.00E-06 1.93E-02 9.67E-08 2.90E-07 5.76E-05 4.42E-05 -4.35 290.8
Addition #3 5.045E-03 5.00E-06 1.93E-02 9.67E-08 3.87E-07 7.67E-05 2.56E-05 -4.59 281.6
Addition #4 5.050E-03 5.00E-06 1.93E-02 9.67E-08 4.84E-07 9.57E-05 8.73E-06 -5.06 265.6
Addition #5 5.055E-03 5.00E-06 1.93E-02 9.67E-08 5.80E-07 1.15E-04 1.90E-06 -5.72 250
Addition #6 5.060E-03 5.00E-06 1.93E-02 9.67E-08 6.77E-07 1.34E-04 8.86E-07 -6.05 241.6
Addition #7 5.070E-03 1.00E-05 1.93E-02 1.93E-07 8.70E-07 1.72E-04 4.19E-07 -6.38 231.2
Addition #8 5.100E-03 3.00E-05 1.93E-02 5.80E-07 1.45E-06 2.84E-04 1.62E-07 -6.79 217
Addition #9 5.200E-03 1.00E-04 1.93E-02 1.93E-06 3.38E-06 6.51E-04 5.42E-08 -7.27 200
Addition #10 5.300E-03 1.00E-04 9.67E-02 9.67E-06 1.31E-05 2.46E-03 1.26E-08 -7.90 180
100
150
200
250
300
350
-9 -8 -7 -6 -5 -4 -3 -2 -1 0
m
V
p[Ca2+]
Ca2+-ISE #2 Calibration
Ca2+ Additions Chelator Response
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3.2.3 ATP Hydrolysis Measurements 
The Ca2+-ATPase uses the hydrolysis of ATP (adenosine tri-phosphate) to drive 
Ca2+ into the SR against the Ca2+ gradient. The products of ATP hydrolysis are 
(adenosine di-phosphate) ADP and phosphate. ADP then reacts with 
phosphoenolpyruvate and the catalyst pyruvate kinase to regenerate ATP and 
pyruvate. Pyruvate (with lactate dehydrogenase (LD)) then oxidizes NADH to 
NAD+ and lactate. NADH has a characteristic absorption at 340nm. Since the 
oxidation of one mole of NADH corresponds to the hydrolysis of one mole of ATP, 
the activity of the Ca2+ ATPase can be quantified by measuring NADH oxidation 
in a spectrophotometer. The rate of ATP hydrolysis can be modulated by 
increasing or decreasing resistance to the pumping of calcium. The Ca2+ 
ionophore A23187 eliminates the Ca2+ gradient between the inside and outside 
of the SR vesicles allowing the pump to run at full speed hydrolyzing ATP. 
Addition of EGTA to achieve sub-µM [Ca2+] will inhibit the Ca2+ dependent Ca2+-
ATPase and inhibit hydrolysis of ATP.   
3.2.4 Anthocyanidin Preparations 
Anthocyanidin stock solutions are prepared by dissolving in EtOH at typical 
concentrations of 1mM to 10mM. This stock is dispensed into 0.2ml PCR tubes 
to obtain desired amount of the anthocyanidin. The tubes are left open and 
placed in a laboratory hood with warm air passed over them and the EtOH is 
allowed to evaporate (approximately 1 hour). Tubes are then closed and placed 
in a container with desiccant and stored in a lab freezer (~-10 C) until needed. 
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On the day of use, the anthocyanidin is removed from freezer and allowed to 
come to room temperature. The required amount of acidified MeOH (+0.1% HCl) 
is added to the tube to obtain the desired stock concentration. The HCl is added 
to ensure the formation of only the flavylium cation in the stock solution. 
References in this work to MeOH being utilized for anthocyanidin stock solutions 
and controls all have 0.1% HCl included although it may not be specifically noted.  
3.2.5 Spectral Studies 
Spectral measurements are performed on either a HP 8452 or an Agilent 8453 
diode array spectrophotometer. A disposable, 4.5 ml, sample cuvette is filled with 
1ml - 2 ml of buffer or solvent at various pH’s and anthocyanidin stock is pipetted 
into the cuvette. The cuvette is under constant stirring via an air driven magnetic 
stirring fixture in the spectrophotometer stage.  
Concentration of anthocyanidin stock is determined by appropriate dilution and 
utilization of Beer’s Law ( A dcε= ). The molar absorptivity coefficient was 
obtained from Extrasynthese. Pelargonidin(ε@523nm) = 32400 ± 1500  (in 
MeOH+0.1%HCl). 
 
3.3 Controls 
3.3.1 MeOH effects on calcium release rate 
Anthocyanidins are not appreciably soluble in water due to the lack of the sugar 
groups that the naturally occurring anthocyanins possess. To prepare the 
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anthocyanidins in stock a concentration that is required for their practical use in 
these experiments, they were made up in MeOH+0.1% HCl.  Although they are 
also soluble in EtOH and DMSO, those solvents were generally not used here 
(unless noted) due to their possible secondary effects seen in previous work 
(results not shown).  
The anthocyanidin stock concentration used for these experiments ranged from 
approximately 1mM to 10mM. The working concentrations obtained after dilution 
in the 2ml working buffer were generally in the range from 1μM to 50μM. Using a 
10mM stock solution of the anthocyanidin and a targeted final concentration of 
50μM, the final MeOH concentration in the working buffer is 0.5%. The effect that 
0.5% MeOH+0.1%HCl (± irradiation) has on the modulation of Ca2+ efflux from 
the SR is measured.  
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Figure 3.3 IRCR and CMCR Effux Rates for Control vs 0.5%MeOH vs 
0.5%MeOH+hν  
 
Experiments shown were performed in a 100mM KCl 20mM PIPES efflux buffer 
at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 + 30μM ATP 
(premixed). At uptake minimum [Ca2+]~1 μM. Efflux initiated by either 0.5% buffer 
(Control), 0.5%MeOH+0.1%HCL, 0.5%MeOH+0.1%HCL plus irradiation (+hν) 
additions. IRCR [Control = 0.0018±0.0011μM/s, 0.5% MeOH+0.1%HCl = 
0.0011±0.0004μM/s, 0.5% MeOH+0.1%HCl +hν = 0.0022±0.0001μM/s]  
CMCR [Control = 0.0074±0.0010μM/s, 0.5% MeOH+0.1%HCl = 
0.0070±0.0004μM/s, 0.5% MeOH+0.1%HCl +hν = 0.0066±0.0002μM/s] 
Dual fiber light at 50% intensity during the release phase. (n=3±SD)  
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The results (Figure 3.3) indicate that neither MeOH nor MeOH plus irradiation 
with white light modulate the efflux from the SR. Additional experiments with both 
lower and higher concentrations of MeOH (0.25% and 1%) have also shown a 
non-modulating effect (results not shown).  
 
3.3.2 Pg, Cy, Dp do not inhibit the Ca2+ -ATPase of the sSR. 
Consistent Ca2+-ATPase activity of the sSR is critical to the accurate 
characterization of the CRC. Abrupt inhibition of the Ca2+-ATPase activity can 
manifest itself as a stimulation of Ca2+ efflux. Conversely, an abrupt 
enhancement of ATPase activity could be interpreted as an inhibition of the CRC.  
To eliminate the possibility that the three anthocyanidins Pg, Cy, and Dp 
modulate the Ca2+-ATPase of the sSR and this effect alone or in part causes the 
apparent stimulated release from the sSR, an experiment measuring the activity 
of the Ca2+-ATPase of the sSR is conducted (Figure 3.4). The rate of NADH 
oxidation (and indirectly the rate of Ca2+-ATPase activity) is not affected by the 
presence of 20µM anthocyanidin. A23187 causes a significant increase in NADH 
oxidation rate but the addition of 20µM anthocyanidin does not significantly 
modulate the A23187 dependent rate. 10mM EGTA eliminates the effect of 
A23187 by chelating the free Ca2+ (the substrate for the ATPase) and thus 
preventing ATPase activity and NADH oxidation (results not shown).  
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 Figure 3.4 Rate of A23187 Dependent NADH oxidation rate by sSR is not 
altered significantly by the addition of 20μM Pg, Cy, or Dp.  
 
100mM KCl, 20mM MOPS pH7, 5un/ml pyruvate kinase, 0.9mM 
phosphoenolpyruvate, 5un/ml lactate dehydrogenase, 0.5mM Mg2+ATP, 
0.125mg/ml sSR, 0.3mM NADH, 1μM A23187. 
Following units in (μmol/mg/min) Pg [0.5%DMSO = 0.15±0.01, A23187 = 
0.61±0.07, Pg = 0.66±0.02] Cy [0.5%DMSO = 0.16±0.00, A23187 = 0.76±0.03, 
Cy = 0.81±0.03] Dp [0.5%DMSO = 0.19±0.02, A23187 = 0.77±0.05, Dp = 
0.82±0.04] (n=2 ±SD) 
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3.3.3 Pelargonidin Hydration Kinetics 
Pelargonidin hydrates to its colorless forms (hemiketal and chalcones) in a 
similar time frame as the duration of time required for CMCR efflux to occur. 
Therefore, the change of Pg concentration during the course of the experiment is 
considered. To calculate the concentration of the prototropic colored forms of [Pg] 
that exist in the efflux assay at any given time point, the apparent kinetic constant 
of Pg hydration is measured and utilized.  
Pelargonidin is made in MeOH-0.1%HCl at 1mM – 10mM stock concentrations 
and then diluted into buffers at pH 5.8, 6.4, and 7.4 under constant stirring at 
room temperature (~22 C). The absorbance peak (at the tested pH) is then 
followed and recorded vs time on a spectrophotometer (HP 8452). The data 
obtained is normalized and fit to a double exponential for use in concentration 
analysis as described in the results section. Normalization of the data to the first 
data point introduces error due to the delay from the actual time of Pg dilution 
and the time that the absorbance is recorded by the spectrophotometer, however 
these kinetics are only used to estimate Pg concentration and this error is 
acceptable in this case. The kinetics of hydration of Pg at pH 5.8, pH 6.4, and pH 
7.4 are shown in Figure 3.5, Figure 3.6, and Figure 3.7 respectively. 
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Figure 3.5 Pg Hydration Kinetics at pH 5.8 
 
A) Mole fraction of Pg prototropic forms vs time of dilution in an aqueous 
buffer at pH 5.8.  
B) Resulting kinetic coefficients of data fit to a 4 parameter double 
exponential decay function. 
Pelargonidin (10μM) is diluted from MeOH+0.1%HCl 1mM stock solution into a 
stirred efflux buffer at the noted pH. The hydration of AH+ is monitored at 532nm, 
normalized to 1, and fit to a 4 parameter double exponential decay function.     
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Figure 3.6 Pg Hydration Kinetics at pH 6.4 
A) Mole fraction of Pg prototropic forms vs time of dilution in an aqueous 
buffer at pH 6.4.  
B) Resulting kinetic coefficients of data fit to a 4 parameter double 
exponential decay function. 
Pelargonidin (10μM) is diluted from MeOH+0.1%HCl 1mM stock solution into a 
stirred efflux buffer at the noted pH. The hydration of AH+ is monitored at 542nm, 
normalized to 1, and fit to a 4 parameter double exponential decay function.     
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Figure 3.7 Pg Hydration Kinetics at pH 7.4 
A) Mole fraction of Pg prototropic forms vs time of dilution in an aqueous 
buffer at pH 7.4.  
B) Resulting kinetic coefficients of data fit to a 4 parameter double 
exponential decay function. 
Pelargonidin (10μM) is diluted from MeOH+0.1%HCl 1mM stock solution into a 
stirred efflux buffer at the noted pH. The hydration of AH+ is monitored at 562nm, 
normalized to 1, and fit to a 4 parameter double exponential decay function.     
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4 Results 
Pelargonidin is a complex natural compound with structural and chemical 
characteristics that directly depend on its immediate environment as well as how 
long it has been subjected to that environment. This results section will show 
what effects Pg has on the modulation of efflux from sSR. 
4.1 Concentration Dependent Modulation of the Initial Rate of Ca2+ Efflux 
from sSR by Varying Concentrations of Pg. 
Pelargonidin is made in MeOH-0.1%HCL stock solutions as described in the 
methods section at concentrations from 1mM to 10mM. Additions are made to 
the sample cuvette containing an efflux buffer (100mM KCl, 20mM HEPES or 
PIPES) under constant stirring. After stock dilution, total MeOH is less 0.5%. At 
low concentrations, the initial release is seen as a slight increase in efflux rate. At 
higher concentrations, the release can be characterized as a rapid transient 
release which quickly disappears to a pseudo steady state condition. Finally, 
release progresses in a way that is similar to a normal CMCR release curve 
(Figure 4.1) except that the CMCR rate is inhibited with respect to the control 
(discussed in the next section). Figure 4.2 shows the concentration dependent 
effect that Pelargonidin has on the IRCR at pH 7.4. The figure shows the results 
from two experimental sets (filled circles and unfilled circles).  
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Figure 4.1 Pelargonidin Stimulates IRCR and Inhibits CMCR in a Concentration 
Dependent Manner (Experimental Trace Examples) 
 
Active efflux experiments were performed in a 100mM KCl 20mM PIPES efflux 
buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 + 
30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM the indicated amount of 
[Pg] was added to the assay.  
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 Figure 4.2  Pelargonidin Stimulates IRCR from sSR at pH 7.4 in a 
Concentration Dependent Manner. 
 
Active efflux experiments were performed in a 100mM KCl 20mM PIPES efflux 
buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 + 
30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM the indicated amount of 
[Pg] was added to the assay. EC50 = 18.9±2.3 μM  (n=2  ±SE). 
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The results show that Pelargonidin stimulates IRCR from actively loaded sSR in 
a concentration dependent manner. Since the concentration of Pg is changing in 
solution with time (very minimal effect for initial rate calculations) and there are a 
mixture of Pg forms present, a typical dose-response analysis for Pg in general 
isn’t very significant. However, when the data is fitted to a dose-response curve, 
a EC50 of 18.9μM ± 2.3μM SE at pH 7.4 is calculated.  
 
4.2 Concentration Dependent Modulation of the CMCR Rate of Ca2+ Efflux 
from sSR by Varying Concentrations of Pg. 
Pelargonidin inhibits the CMCR phase in a concentration dependent manner 
(Figure 4.3) It is a unique property for a CRC modulator to exhibit this type of 
dual modulating effect. Again, the fit of a dose-response curve has limited validity 
here especially for CMCR analysis where Pg is in a mixture of forms and the 
concentration of the specific forms are changing with respect to each other with 
time. However, when a fit is performed, an IC50 of 13.3μM ± 0.5μM is calculated. 
More relevant EC50 and IC50 information will be presented in Sections Figure 4.4 
and Figure 4.5 
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Figure 4.3  Pelargonidin Inhibits CMCR Rate from sSR at pH 7.4 in a 
Concentration Dependent Manner. 
 
Active efflux experiments were performed in a 100mM KCl 20mM PIPES efflux 
buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 + 
30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM the indicated amount of 
[Pg] was added to the assay. IC50 = 13.3 ± 0.5μM  (n=2  ±SE) 
   
  
 58 
4.3 Modulation of Efflux from sSR by Pelargonidin vs Time of Dilution. 
In an effort to elucidate what forms of Pg may be responsible for its effect on the 
sSR, the efflux rate verses the time of dilution (TOD) of Pg in an aqueous buffer 
is measured. As mentioned in chapter 2, upon dilution into an aqueous solution 
at greater than acidic pH, Pg immediately transforms into a mixture of forms. The 
mole fraction of the forms that exist and the kinetics of transformation into other 
forms is dependent on the pH of the buffer. The transformation to the different 
forms can be roughly separated into two (time-domain) groups. The first group is 
the colored prototropic group is composed of the flavylium cation, the quinoidal 
base, and ionized quinoidal base. The prototropic form equilibrates in sub-
seconds with the mole fraction of each form dependent on the pH of the dilution 
buffer. The prototropic forms then are more slowly (minutes to hours) 
transformed to the ‘colorless’ forms (hemiketal, cis-chalcone, and trans-chalcone) 
by hydration of the flavylium cation. In this experiment, Pelargonidin is pre-diluted 
into a pH 5.8 buffer and allowed to undergo its transformation to the colorless 
forms. During the transformation, samples of the diluted stock are taken and 
used in the active efflux assay.  
4.3.1 Initial Rate of Ca2+ Efflux by 30μM Pg Pre-buffered at pH 5.8 vs Time 
of Dilution 
Figure 4.4 shows the IRCR of 30μM Pg verse Time of Dilution (top). As the time 
of dilution is allowed to progress, the IRCR stimulation effect of Pg decreases 
indicating the loss of a IRCR stimulating form or forms. The IRCR is plotted 
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against the calculated [Pg] (from Pg hydration kinetics) (bottom) that corresponds 
to the time of dilution. The fitted EC50 is 17.7μM ± 3μM (SE). The time of dilution 
axis is included as a reference and estimate only. This result implies that the 
colored prototropic forms (AH+, A, A-) which are decreasing in concentration with 
time, are responsible for the stimulated IRCR effect caused by Pelargonidin.  
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 Figure 4.4 IRCR Stimulation by 30μM Pg Decreases with Respect to Time 
when Pre-diluted in a pH 5.8 Efflux Buffer 
 
Top: IRCR vs TOD. Bottom: IRCR vs calculated [Pg] based on Pg’s measured 
hydration kinetics (section 3.2.5). Data fit to a four parameter logistic curve - EC50 
= 17.7μM ± 3μM r2=0.77 (S.E. n=2). Experiments performed in a 100mM KCl 
20mM PIPES efflux buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 
60μM MgCl2 + 30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM the 
indicated amount of [Pg] was added to the assay. Pg was pre-diluted into a pH 
5.8 efflux buffer at 2mM (time=0). 2mM aqueous stock was then added to efflux 
assay to obtain 30μM Pg.   
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4.3.2 CMCR Efflux by 30μM Pg Pre-buffered at pH 5.8 vs Time of Dilution 
This experiment is the same as shown for the previous (IRCR) section except 
that CMCR is calculated and reported. As time of dilution is allowed to progress, 
the CMCR rate increases (Figure 4.5) indicating a loss of inhibition. The CMCR 
rate is plotted against the calculated [Pg] (from Pg hydration kinetics) that  
corresponds to the time of dilution. The fitted IC50 is 12.9μM ± 0.1μM (SE). The 
time of dilution axis is included as a reference and estimate only. The individual 
pH dependent prototropic forms present in this experiment are the same forms 
present in the concentration dependent experiment (Figure 4.3). Therefore, the 
form or forms responsible for the inhibited CMCR rates with increasing 
concentration are probably responsible for the increasing rate (with decreasing 
concentration) here. That is, the disappearing inhibition effect is most likely due 
to a decrease in concentration of an inhibiting Pg form. This result implies that 
one or more of the prototropic forms are responsible for the CMCR inhibition 
effect. Given that this experiment is performed in pH 7.4 buffer, which minimizes 
the cationic form to <1% (see Figure 4.7), the quinoidal base form or the ionized 
quinoidal base form (or both) are likely responsible for CMCR inhibition.   
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 Figure 4.5 CMCR Inhibition by 30μM Pg Decreases with Respect to Time when 
Pre-diluted in a pH 5.8 Efflux Buffer 
 
Top: CMCR vs TOD. Bottom: CMCR vs calculated [Pg] based on Pg’s measured 
hydration kinetics (section 3.2.5). Data fit to a four parameter logistic curve - IC50 
= 12.9μM ± 0.1μM r2=0.90 (S.E. n=2). Experiments performed in a 100mM KCl 
20mM PIPES efflux buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 
60μM MgCl2 + 30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM the 
indicated amount of [Pg] was added to the assay. Pg was pre-diluted into a pH 
5.8 efflux buffer at 2mM (time=0). 2mM aqueous stock was then added to efflux 
assay to obtain 30μM Pg.   
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4.4 pH Dependent Modulation of Ca2+ Efflux by Pg 
The results presented in section 4.2 and 4.3 strongly implies that one or more of 
the three prototropic forms as being the main modulating species for both IRCR 
stimulation and CMCR inhibition.  
The species included in the prototropic group are the flavylium cation (AH+), the 
quinoidal base (A), and the ionized quinoidal base (A-) with the specific mole 
fraction of each being pH dependent. The first pKa (experimental) and second 
pKa (calculated) of Pelargonidin are reported to be at pH 5.8 and pH 7.1 
respectively (Borkowski et al. 2005). Figure 4.6 shows a calculated mole fraction 
diagram of Pelargonidin for the prototropic forms based on those pK values. At 
pH 5.8 the calculated mole fractions of AH+, A, and A- are 49%, 49%, and ~1% 
respectively. At pH 6.4, the mole fractions are 17%, 70%, and 13% respectively. 
And at pH 7.4, the mole fractions are ~1%, 33%, and 66%% respectively (Figure 
4.7). 
The pH extremes tested here, pH 5.8 and pH 7.4, were chosen mainly due to the 
functionality limit of the sSR. Lastly, pH 6.4 is chosen because it fit at the 
predicted maximum of [A] and the predicted minimum of [AH+] and [A-] (Figure 
4.6). 
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Figure 4.6 Reference Chart of the Mole Fractions of the Prototropic Forms of 
Pg vs pH Immediately After Dilution into an Aqueous Buffer  
 
Chart shows the calculated mole fractions of the flavylium cation (AH+), the 
quinoidal base (A), and the ionized quinoidal base (A-) of Pelargonidin vs pH. 
First pKa1=5.8 and second pKa2=7.1 were taken from Borkowski et al. 2005. 
Efflux assay pH at 5.8, 6.4, and 7.4 are indicated for reference.   
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Figure 4.7 Calculated Mole Fractions of the Prototropic Forms of Pg vs pH 
Immediately After Dilution into an Aqueous Buffer 
 
Chart shows the calculated mole fractions of AH+, A, A- of Pelargonidin at pH 5.8, 
6.4, and 7.4. First pKa1=5.8 and second pKa2=7.1 were taken from Borkowski et 
al. 2005. Data shown below. 
 
 
  
AH+ A A-
pH 5.8 49% 49% 2%
pH 6.4 17% 70% 13%
pH 7.4 1.00% 33% 66%
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4.4.1 pH Dependent IRCR by 30μM Pg 
A comparison between a control (MeOH+0.1%HCl), 0.5mM caffeine, and 30μM 
Pg is made. Caffeine is utilized because the control has a very low (nearly zero) 
initial rate of efflux which can have limited use when making comparisons to a 
modulating compound. Additionally, caffeine is a well-known stimulator of the 
CRC that has a first pKa ~ 14 and therefore will not ionize over the tested pH 
range. However, that doesn’t preclude that the efficacy of caffeine stimulation of 
the CRC doesn’t change over the tested pH range (due to pH dependent 
changes of the CRC itself).  
As mentioned in Chapter 1, the CRC is very sensitive to pH. At low pH (<6), the 
CRC is in a near closed state and is resistant to stimulation. At high pH (>7.4), 
the CRC is in a relatively open state. Therefore, the comparison of the effects of 
Pg on the CRC/sSR across a pH range must be approached with caution. For 
reference, Figure 4.8 shows actual experimental traces and the relative 
difference of efflux kinetics for a control (0.5%MeOH) experiment at pH 5.8, 6.4, 
and 7.4.  
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Figure 4.8  The Uptake and Efflux Kinetics of sSR Active Efflux Experiments are 
pH Dependent  
 
Active efflux control experiments were performed in a 100mM KCl 20mM PIPES 
efflux buffer at pH 5.8, 6.4, and 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 
5-60μM MgCl2 + 5-30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM 
0.5%MeOH was added to the assay. 
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The result shown in Figure 4.9 shows the IRCR results for 0.5% MeOH (control), 
0.5mM caffeine, and 30μM Pg at pH 5.8, pH 6.4, and pH 7.4. The IRCR for 
MeOH (black bars) increases with increasing pH confirming the pH dependent 
modulation of the CRC. The 0.5mM caffeine columns (light gray columns in each 
pH set) show a significant stimulation over the pH dependent increase of the 
control. Finally, the 30μM Pg columns (dark gray columns in each pH set) also 
show a stimulation effect that increases with pH. However, the level of IRCR 
stimulation is similar to that of 0.5mM caffeine at pH 5.8 and pH 6.4 but at pH 7.4, 
stimulation is only 55% that of caffeine. Given the pH dependent complexity of 
Pg, this could imply that Pg is losing its ability to stimulate IRCR at this (high) pH 
because of a loss of stimulating species (loss of AH+ or A) or because of an 
increase of an inhibiting form (A-). Since the comparison is made to caffeine, a 
look at it is also warranted. Even though caffeine isn’t ionizing over this pH range, 
there is the possibility that the pH dependent changes of the CRC is altering 
(enhancing in this case) the efficacy of caffeine to stimulate IRCR. This data 
doesn’t substantiate this possibility very well if one looks at the data with the 
MeOH IRCR rates normalized (Figure 4.10). Again, the rates for caffeine and Pg 
are comparable at pH 5.8 and pH 6.4. At pH 7.4 the normalized caffeine IRCR 
rate is comparable to its normalized rate at pH 6.4. If the efficacy of caffeine is 
enhanced when changing from pH 6.4 to pH 7.4, then one would expect the 
normalized rate to increase from that at pH 6.4 which isn’t apparent from the 
results presented.  
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4.4.2 pH Dependent CMCR by 30μM Pg 
It is important to note that there are two distinct changes in the time domain 
occurring that is distinct for each pH. First, the duration of time required to get 
from the addition of Pg to the time point where the CMCR is calculated is 
decreasing with increasing pH. Second, the rate of transformation of Pg is 
decreasing with increasing pH. So, the estimated concentration of the Pg forms 
present at any given CMCR point must use the appropriate combination of the 
two time based factors. It is worth noting that the consideration of the pH and 
time factors listed above are significant if the effect of Pg on the sSR is reversible. 
That is, the modulating effect by Pg is caused by the concentration of the Pg 
forms present at the time of CMCR, not at the time Pg is added to the assay. The 
analysis presented here assumes a reversible process and therefore the loss of 
[Pg] with time is considered. This assumption is only supported by the fact that 
the effect of Pg on IRCR is transitory which may imply a reversible process. If the 
inhibition of CMCR by Pg is not reversible, then the impact of the incorrect 
assumption and analysis will result in an artificially low IC50 for CMCR modulation 
by Pg. To determine if the effects of Pg are indeed reversible or not, other  
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Figure 4.9 IRCR Stimulation of Ca2+ Efflux by 30μM Pg and 0.5mM Caffeine 
vs pH 
 
Active efflux control experiments were performed in a 100mM KCl 20mM PIPES 
efflux buffer at pH 5.8, 6.4, and 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 
5-60μM MgCl2 + 5-30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM either 
0.5%MeOH, 30μM Pg, or 0.5mM caffeine was added to the assay. Data shown 
below. (n=3 ±SD). All rates below are in nmol/mg/min.  
 
 0.5% MeOH 0.5mM Caffeine 30μM Pg 
pH5.8 0.15±0.13 0.36±0.11 0.40±0.04 
pH6.4 0.30±0.14 1.73±0.14 1.61±0.52 
pH7.4 1.43±0.62 7.81±1.28 4.48±10.9 
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 Figure 4.10 Control Normalized IRCR by 30μM Pg vs pH  
 
Control normalized IRCR comparisons for 0.5% MeOH+0.1%HCl, 0.5mM 
caffeine, and 30μM at pH 5.8, 6.4, and 7.4. Experiments were performed as 
noted in Figure 4.9. Data shown below. 
 
 0.5% MeOH 0.5mM Caffeine 30μM Pg 
pH5.8 1 2.4±0.9 2.6±0.9 
pH6.4 1 5.8±0.5 5.4±0.6 
pH7.4 1 5.5±0.5 3.1±0.5 
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experiments such as single channel work would need to be completed (but are 
not included here). 
Figure 4.11 shows that the CMCR rate for the control increases with pH as 
expected. Caffeine also stimulates CMCR at pH 5.8 and pH 6.4. At pH 7.4, the 
CMCR rate for 0.5mM caffeine is comparable to the MeOH control. 30μM Pg 
stimulates CMCR on the same order as caffeine at pH 5.8. However, at pH 6.4 
and pH 7.4, Pg inhibits the CMCR rate significantly. Figure 4.12 shows the same 
data from Figure 4.11 as a percentage increase or decrease in CMCR rate 
compared to the control. Pg stimulates CMCR by 49% at pH 5.8. CMCR is 
inhibited by Pg to 50% less at pH 6.4 and to 58% less at pH 7.4 with respect to 
the control.  
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 Figure 4.11 CMCR Modulation of Ca2+ Efflux by 30μM Pg and 0.5mM Caffeine vs 
pH 
 
CMCR comparisons for 0.5% MeOH+0.1%HCl, 0.5mM caffeine, and 30μM at pH 
5.8, 6.4, and 7.4. Experiments were performed in a 100 mM KCl, 20 mM PIPES 
efflux buffer at the stated pH, 0.15mg/ml crude sSR vesicles were actively loaded 
with ~5μM Ca2+ by Ca2+-ATPase activity with 5-60μM MgCl2 + 5-30μM ATP. At 
uptake minimum [Ca2+]~1 μM. (n=3 ±SD). All rates below are in nmol/mg/min.  
 
 0.5% MeOH 0.5mM Caffeine 30μM Pg 
pH5.8 0.32±0.05 0.47±0.06 0.47±0.06 
pH6.4 1.86±0.11 2.53±0.33 0.93±0.12 
pH7.4 8.61±1.07 7.26±2.47 3.58±0.77 
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Figure 4.12 % Difference of 30μM Pg Modulation of the CMCR Rate of Ca2+ 
Efflux with Respect to the 0.5%MeOH control vs pH 
 
Data from Figure 4.11 represented as the % Difference of 30μM Pg Modulation of 
the CMCR Rate of Ca2+ Efflux with Respect to the 0.5%MeOH control at pH 5.8 
(49%±26%), pH 6.4 (-50%±17%), pH 7.4 (-58%±4%). 
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4.4.3 Comparison of Pg Effects on CMCR Efflux and the Relative 
Calculated Concentration of the Prototropic Forms of Pg 
As mentioned at the beginning of this section, this analysis assumes that the 
binding, and resulting modulation, of Pg to the CRC is a reversible process. To 
estimate the concentration of the three prototropic forms of Pg at the time that 
the CMCR is calculated, both the kinetics of transformation and the calculated 
mole fraction of the Pg forms at pH 5.8, 6.8, and 7.4 are considered. 
The table at the bottom of Figure 4.13 lists the time duration between the point of 
Pg addition to the assay to the point at which the CMCR rate determined at each 
pH. The ‘%Pg Remaining’ is calculated using the CMCR(Δt) data as the time 
variable in the equations, as measured and fitted, for Pg kinetics at each pH 
(Figure 3.5, Figure 3.6, and Figure 3.7). The ‘Mole Fraction’ data is taken from 
Figure 4.7. Finally, the ‘Calculated [Pg form]’ is the product of the initial Pg 
concentration (30 μM), the Mole Fraction of each Pg form at that specific pH, and 
the percent of Pg left at the time that the CMCR data point is taken (Equation 
4.1). 
[𝑃𝑔 𝑓𝑜𝑟𝑚]𝑐𝑎𝑙𝑐. = [𝑃𝑔]𝑖𝑛𝑖 ∗ �[𝑃𝑔 𝑓𝑜𝑟𝑚][𝑃𝑔]𝑖𝑛𝑖 � ∗ �[𝑃𝑔 𝑅𝑒𝑚𝑎𝑖𝑛𝑖𝑛𝑔][𝑃𝑔]𝑖𝑛𝑖 �𝑡𝑖𝑚𝑒=𝐶𝑀𝐶𝑅 
Equation 4.1 
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Figure 4.13 Time Adjusted Concentration of the Pg Prototropic Forms at 
CMCR(Δt) vs pH.  
 
Top: Bar chart comparing the calculated [AH+], [A], and [A-] at each pH and at 
CMCR(Δt) with 30μM initial Pg concentration. . 
Bottom: Data used to calculate [AH+], [A], and [A-] with [Pg]ini = 30 μM. (n=3 ±SD) 
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The chart at the top of Figure 4.13 compares the calculated [AH+], [A], and [A-] 
concentrations at each pH with an initial [Pg] of 30 μM. It is interesting to 
compare this data to Figure 4.7 which is the calculated mole fraction data at time 
of Pg addition into each buffer. Although the trends remain similar, the CMCR 
(time adjusted) data shows that the concentrations of the [AH+] and [A] forms at 
pH 5.8 are significantly lower than the [A] and [A-] forms at pH 7.4. This is a direct 
result of the slower transformation kinetics of Pg at higher pH. 
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4.5 Light Dependent Modulation of Ca2+ Efflux from sSR by Pg 
Arguably the most interesting property that Pg possesses with regards to its 
effect on the CRC is its effect when irradiated with white light. When irradiated, 
the CMCR inhibition shown in the previous sections is essentially nullified (Figure 
4.14). That is, when irradiated, the CMCR rate increases to similar values as 
seem for the CMCR of the control.  
 
4.5.1 Light Dependent IRCR vs pH 
Figure 4.15 shows the pH dependent initial rate of efflux results for the MeOH 
(control) and 30μM Pg as previously reported (two left most bars at each pH). 
Additionally, the IRCR rate for 30μM Pg (+hν) that is irradiated with white light for 
the duration of the efflux phase is also shown. There isn’t a significant difference 
between IRCR stimulation by Pg with or without irradiation.  
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Figure 4.14  Irradiation with White Light Removes CMCR Inhibition by 30μM Pg 
(Example Trace) 
 
Active efflux control experiments were performed in a 100mM KCl 20mM PIPES 
efflux buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 
+30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM 0.5%MeOH was added 
to the assay. 
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Figure 4.15 IRCR Modulation of Active Ca2+ Efflux by 30μM Pg with and without 
Irradiation by White Light 
 
Active efflux control experiments were performed in a 100mM KCl 20mM PIPES 
efflux buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 
+ 30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM 0.5%MeOH or 30μM 
Pg was added to the assay. For +hν experiments, light was turned on at the 
same time as the Pg was added. Data shown below. (n=3 ±SD). All rates below 
are in nmol/mg/min.  
 
 0.5% MeOH 30μM Pg 30μM Pg + hν 
pH5.8 0.15±0.13 0.36±0.11 0.40±0.04 
pH6.4 0.30±0.14 1.73±0.14 1.61±0.52 
pH7.4 1.43±0.62 7.81±1.28 4.48±1.09 
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4.5.2 Light Dependent CMCR Rate of Ca2+ Efflux vs pH 
Figure 4.16 shows the comparison of CMCR results for 30μM Pg without and 
with irradiation vs the control. The CMCR efflux results for the MeOH (control) 
and 30μM Pg are as shown as the two left most bars at each pH (black and light 
grey bars). The right most bars (dark grey) show the CMCR rate for 30μM Pg 
that is irradiated with white light (+hν). Irradiation is started at the same time Pg 
is added to the assay. With irradiation, the CMCR rate returns to a value very 
comparable to the MeOH rate. There is even a slight increase in CMCR rates at 
pH 5.8 and pH 6.4 however the increases are small and a larger statistical data 
set would be needed for the stimulation result to be convincing. Similarly, the 
CMCR rate at pH 7.4 is slightly less than the control (with the same reservation). 
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Figure 4.16 CMCR Modulation of Active Ca2+ Efflux by 30μM Pg with and 
without Irradiation by White Light 
 
Active efflux control experiments were performed in a 100mM KCl 20mM PIPES 
efflux buffer at pH 7.4. ~0.15mg/ml sSR + ~5μM CaCl2 (premixed), 60μM MgCl2 
+ 30μM ATP (premixed). At uptake minimum [Ca2+]~1 μM 0.5%MeOH or 30μM 
Pg was added to the assay. For +hν experiments, light was turned on at the 
same time as the Pg was added. Data shown below. (n=3 ±SD). All rates below 
are in nmol/mg/min.   
 
 0.5% MeOH 30μM Pg 30μM Pg + hν 
pH5.8 0.32±0.05 0.47±0.06 0.47±0.06 
pH6.4 1.86±0.11 2.53±0.33 0.93±0.12 
pH7.4 8.61±1.07 7.26±2.47 3.58±0.77 
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5 Discussion 
Pelargonidin has an interesting and complex modulating effect on sSR. In active 
efflux experiments performed at pH 7.4, it stimulates IRCR and inhibits CMCR in 
a concentration dependent manner over the concentrations assayed (0.5µM – 
45µM). 
It has been shown in this work that out of the several forms of Pelargonidin that 
exist in aqueous solution within the working physiological pH range of the CRC, 
the colored prototropic forms including the flavylium cation, quiniodal base, and 
ionized quinoidal base, are responsible for the modulating effects on the CRC. 
This was confirmed with ‘time of dilution’ experiments where both the loss of 
IRCR stimulation and loss of CMCR inhibition corresponded with a concurrent 
loss of the colored forms of Pelargonidin. However, the modulating effects of the 
hemiketal and chalcone forms of Pelargonidin were not explicitly assayed for 
their possible modulating effects and therefore should not be discounted as 
possible CRC modulators.  
The respective mole fractions of the prototropic forms responsible for modulation 
can be shifted with pH. Experiments were performed at three different pH’s in an 
effort to isolate the different forms and their effects on modulation of CRC Ca2+ 
efflux. The CRC’s functional pH range didn’t allow for the complete isolation of 
the individual colored forms of Pg, however, a significant shift in the mole 
fractions of each of the three forms was achieved. Unfortunately, the form(s) 
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responsible for stimulation of IRCR is difficult to confirm mainly because IRCR 
stimulation with persisted across all three pH’s assayed. Even so, the result at 
pH 7.4 does provide evidence that there is a Pg related pH dependent variable at 
play. The amount of stimulation by Pg decreases by ~50% with respect to that of 
0.5mM caffeine at pH 7.4. The difference in efficacy between caffeine and Pg 
across the pH jump from pH 6.4 to pH 7.4 could be explained by either an 
increase in the stimulation efficacy of caffeine or a decrease in stimulation 
efficacy of Pg (or possibly both). However, when the pH dependent IRCR data is 
normalized to the control, caffeine doesn’t stimulate efflux any more at pH 7.4 
than at pH 6.4 implying that it is not gaining efficacy. It should be noted that 1mM 
caffeine did significantly increase stimulation at pH 7.4 indicating that the CRC 
isn’t fully stimulated by 0.5 mM caffeine (results not shown). So it seems 
probable that Pg is losing its stimulation ability or possibly gaining a competitive 
inhibitory nature (or both) with an increasing experimental pH. The persistent 
IRCR stimulation with increasing pH may also be clouded due to a possible 
experimental design flaw. The stock solution of Pg is in acidified MeOH which 
stabilizes the cationic form. When Pg is added to the assay, it is being added as 
AH+. There will be a very short amount of time within the mixing time that the AH+ 
form could potentially interact with a fraction of the sSR prior to its deprotonating 
to the A or A- forms (irrespective of pH). If real, this interaction could essentially 
minimize the buffer pH as an effective assay variable for Pg form isolation with 
regards to IRCR determination. This problem could be overcome by first pre-
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diluting Pg into the same efflux buffer with the same pH that is being assayed for 
efflux. This would theoretically establish the desired prototropic forms prior to 
addition to the efflux assay. Additional possible evidence for ‘contamination’ by 
AH+ in the stock solution is the transient nature of the stimulation phase (see the 
30μM Pg trace in Figure 3.1) at the higher pH’s that implies a transient, 
disappearing species such as AH+ at high pH. Stimulation at pH 5.8 doesn’t show 
the same transient IRCR stimulation characteristics like stimulation by Pg at the 
higher pH’s. This may be due to the persistence (not disappearance) of a 
stimulating species at pH 5.8 (presence of flavylium cation), the lack of an 
inhibiting species at that pH (no ionized quinoidal base), or, possibly both have a 
part to play. Although it is difficult to specifically pin point the form of Pg that is 
stimulating IRCR, the general statement can be made that Pg stimulation, with 
respect to the control, is evident at all pH’s but it is decreasing as the pH is 
increased.  
Inhibition of CMCR efflux from the CRC is also concentration dependent. An 
increase in the Pg concentration causes a decrease in the CMCR rate (an 
increase in inhibition). Also similarly to the IRCR stimulation effects, the inhibition 
effects are also caused by the colored prototropic forms.  
To isolate the prototropic forms responsible for stimulation and inhibition, the 
following argument can be made. CMCR is stimulated at pH 5.8 and inhibited at 
pH 6.4. At pH 5.8, the AH+ and A forms exist with equal calculated 
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concentrations of ~5 μM (Figure 4.13) but when jumping to pH 6.4, the 
concentration of AH+ is only slightly decreasing from ~5μM to ~3μM but A is 
significantly increasing from ~5μM to ~13μM. That essentially rules out A as a 
stimulator which only leaves the option for it being inert or an inhibitor. For the 
same reason, AH+ is identified as a stimulator. When jumping from pH 6.4 to pH 
7.4, CMCR inhibition increases slightly. Concurrently, the concentration of A 
decreases slightly from 13μM to 9μM and the concentration of A- increases 
significantly from 3μM to 17μM. Therefore, A is, again, either inert or an inhibitor, 
and A- is identified as a probable inhibitor.  
 
Figure 5.1   Anthocyanidin Form vs. Proposed Modulator Type 
 
The role of A is a little less certain but seems to point toward one of four 
possibilities. First, it could be a weak stimulator. In this case it supplements the 
more potent stimulating effects of AH+ at pH 5.8 and doesn’t significantly nullify 
the inhibiting effects of A- at pH 6.4 and pH 7.4. Second, it could be a weak 
inhibitor. In this case it doesn’t overpower the stimulating effects of AH+ at pH 5.8 
and supports inhibition of A- at pH 6.4 and pH 7.4. Third, A is a strong inhibitor 
but AH+ is an even stronger stimulator and overpowers A at pH 5.8. The fourth 
AH+ A A-
Stimulating X
Inert X
Inhibiting X X
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possibility is that it is inert and has no effect. The A form doesn’t seem to be a 
strong stimulator because if it was, then its effect should be more noticeable at 
pH 6.4 where there is very little of the A- form. 
 
5.1 Proposed Mechanisms of Stimulation and Inhibition 
You can’t discuss the chemistry and reactivity of anthocyanidins without 
considering their antioxidant (cation radical scavenging) activity. The antioxidant 
activity of anthocyanidins increases with the increasing number of hydroxyl 
groups on the B ring. However, the antioxidant capability of Pelargonidin is not 
very good as compared to other anthocyanins and anthocyanidins due to the lack 
of a catechol or pyrogallo group on its B ring. Additionally, the scavenging activity 
of Pg was not pH dependent like other similar anthocyanidins were. Given that 
pelargonidin’s effect on the CRC is shown in this work to have a pH dependence, 
the antioxidant activity of Pg doesn’t seem to be a likely mechanism of CRC 
modulation by Pg. 
Another interesting and possible mechanism is ground state charge coupling 
where coupling between an electron donor (assigned to the CRC) and the 
anthocyanidin electron acceptor occurs with a driving force being the transfer of 
charge from the donor to the acceptor. It this scenario, the excellent electron 
acceptor properties and charge coupling capability of the AH+ form may be 
primarily responsible for stimulation of the CRC at lower pH. At higher pH, the 
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better electron donor A- form is bound to the CRC modulating site which forces 
an opposite charge shift and a resultant CRC inhibition effect. When A- is excited 
(by irradiation), it becomes a better acid and therefore a better e- acceptor, the 
charge shifts back toward the excited form and inhibitory effect is removed.  
This theory fits well with the current proposed CRC function proposed by the 
Abramson group. It also complements a possible mechanism for the inhibition of 
CMCR as well as the light dependent stimulation/loss of inhibition of CMCR.  
However, the excited states of ionized quinoidal forms have not been studied nor 
substantiated by the literature so this is just a theory.  
Another possible mechanism for the light dependent reaction is related to the 
photochomic behavior of synthetic and natural anthocyanins. At slightly acidic pH, 
anthocyanins and related synthetics compounds will eventually transform to the 
low energy form, the trans-Chalcone. Numerous studies have shown that 
irradiation of the trans-Chalcone form will initiate photoisomerization back to the 
cis-Chalcone and Hemiketal forms eventually giving the prototropic forms 
depending on pH. In the case of these experiments, the pH is sufficiently high 
that the back reaction is unfavored and probably does not have a role in the work 
presented here. 
Yet another possible mechanism for the light dependent reaction is due to 
possible chalcone excited states. It has been reported by the Lima group that the 
two chalcone isomers of Malvin may have different excited state properties with 
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respect to their acid-base equilibria (Lima et al. 1994) and therefore it is likely 
that other anthocyanins have similar properties. The amounts of Chalcone form 
in the work performed here are probably very small. Although the mole fraction of 
the colorless forms aren’t specifically known for Pelargonidin, anthocyanidins 
generally have much more Hemiketal content than Chalcone content in 
equilibrium. This minimizes the potential for this mechanism as being relevant in 
this work.  
5.2 Closing Remarks 
Pelargonidin is a very unique modulator of the CRC. Never before has a 
compound been shown to have stimulating, inhibiting, and light dependent 
modulation effects on the CRC. Pelargonidin is different from most CRC 
modulators in that it exists as a mixture of forms that change with time and with 
pH. Each of the very closely structured forms of Pg have different chemical 
properties and they also have correspondingly different effects on the CRC. This 
result in itself is very important and it supports the recently proposed CRC 
functional theory proposed by the Abramson group that electron donors and 
electron acceptors can have competing modulating effects on the Ca2+ transport 
properties of the CRC.  
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